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ABSTRACT
This research is motivated by some of the challenges faced by the healthcare
community in communicating health information to the public and the potential for usercentered technology design to address some of these limitations. Each year, thousands
die or are injured due to adverse-drug events due to both prescription and over-thecounter medications. The integration of technology has improved the incidence rate for
adverse-drug events due to prescription medications. Similarly, personal health records
and other consumer-based health applications have been shown to be beneficial for
helping individuals manage their health. Despite this growing body of research, little to
no research has been conducted to gauge the possible effectiveness of technology created
through a user-centered design process to assist consumers in understanding similar
events due to over-the-counter medications.
This research explores the implications for the design of interactive technology to
help older adults understand the possible risk of an adverse drug events resulting from
taking over-the-counter (OTC) medications. A user-centered design process was
employed, leveraging various techniques to design technology to assist older adults with
over-the-counter medication information. The three studies conducted for this research
are part of an Exploratory Mixed-Methods Study, designed to identify current practices
and challenges, identify opportunities for technology integration, and to examine the
usability and effectiveness of the resultant technological artifacts for assisting older
adults with over-the-counter medication information. Data collection included semistructure interviews, surveys, questionnaires, and observations. Results from each study
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suggest that the technologies evaluated are useful for assisting older adults with over-thecounter medication information. Design recommendations identified throughout each
phase are presented to provide insight on the technology features found useful and not so
useful by older adults throughout the process of this research.
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CHAPTER ONE
INTRODUCTION
Consumer-based Health Information Technology (HIT) design is a growing area
of interest within the Human-Computer Interaction (HCI) community. However,
research within HCI, which focuses on helping consumers understand health information,
is in its adolescence. Nonetheless, helping people understand health information is a
fertile area where applying user-centered design techniques to consumer-based health
information technology design has been immensely beneficial to better understanding the
design needs of various populations. This has resulted in the design of Consumer Health
Informatics (CHI) applications that helps patients and consumers become more
knowledgeable, involved, and empowered about their personal health. However, because
of the inherent complexity of health information and communicating health, several
challenges still exist.
This research addresses some of the gaps in knowledge that exist related to
communicating over-the-counter (OTC) medication information to older adults. Current
methods for communicating OTC medication information are paper-based or consist of
technologies that rely heavily on the same language used by their paper-based
counterparts. Further, few studies currently exist that focus on how user-centered CHI
applications can play a role in helping older adults better understand OTC medications,
although this is still a major concern among older adults. The major goal of this research
is to better understand and identify ways in which technology may assist older adults in
the process of selecting appropriate OTC medications. Design considerations for a novel
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technological artifact that could assist older adults in the OTC medication selection
process were identified. In addition, the feasibility, usefulness, usability, and short-term
effectiveness of the derived artifact and its components for improving understanding of
and delivering OTC medication risks and benefits for older adults was evaluated.

STUDY DESIGN
A three-phase Exploratory Sequential Mixed-Methods Study was conducted to
better understand how technology might assist older adults in the over-the-counter
selection process. The three phases of the study were conducted over a 2-year period and
each phase of the study informed the design of the next phase. The phases of the study
are outlined below.
Phase I: Understanding the Over-the-Counter Information Needs of Older Adults
The first study examined the current over-the-counter medication needs and
practices of older adults. This phase of research was conducted to better understand older
adults current OTC medication selection practices and any challenges they may have with
OTC medication information. Participants were required to take OTC medication,
purchase their own OTC medication and be 65 years of age or older. Semi-structured
interviews were conducted with 10 older adults that were recruited over the period of 4
months. Interviews were conducted until no new data emerged. Interviews were audio
recorded and later transcribed for analysis. A thematic analysis was conducted and 5
themes emerged related to the participants’ current OTC medication practices. The
themes centered around participants 1) information seeking timeline, 2) barriers to
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identifying OTC medication risks, 3) information needs and concerns, 4) information
sources and 5) challenges with OTC medication information. The data was used to
inform and develop a model of the participants OTC medication selection process.

Phase II: Identifying Design Considerations for Technology to Assist Older Adults
with OTC Decision-Making
The second study identified design considerations for supporting older adults
OTC consumer decision-making through technology. This phase was conducted to 1)
conceptualize and design a novel prototype interface that could assist older adults in OTC
consumer decision-making 2) examine the usability of the prototype for assisting older
adults in the OTC consumer decision-making task and 3) identify aspects of design that
might be useful to help older adults in the specific task of selecting OTC medication.
Participants were required to take OTC medication, purchase their own OTC medication
and be 65 years of age or older. Data collection included results of an expert review
(brainstorming and walkthrough sessions), a round of semi-structured interviews that
included a total of 7 participants, and hand-written notes of observed participant
interactions with the paper-based prototype. Recruitment and data collected occurred
over a period of 6 months. Data from expert review were collected through hand-written
notes and email exchanges. Data was transcribed and content analysis was used to
identify usability concerns. Interviews and participant observation notes were audio
recorded and later transcribed for analysis. Thematic analysis was conducted to identify
key aspects of the design that were found useful by the participants. Five major themes
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emerged that centered various features and functionality of the system. These themes
included: 1) Guided Persuasion, 2) Personalization, Tailoring, and Decision Support, 3)
Trust and System Recommendation, 4) Consumer-Friendly Health Language and 5)
Support for Sharing.

Phase III: Designing and Evaluating a Prototype Translator to Assist Older Adults
with OTC Decision Making
The final study examined the feasibility and effectiveness of a prototype translator
designed to assist older adults with OTC medication information. The translator was
designed through a human-centered process in which information needs were gathered
and later included in a prototype to elicit additional feedback from participants. The
results of prior studies were used to inform the design of the translator being examined in
the proposed study. Twenty-one older adults, 65 years of age or older, were recruited to
examine the effectiveness of the translator. Data for background information, health
literacy, control beliefs, perceived and actual difficulty of the information, and user
satisfaction were collected. Recruitment and data was collected over a period of 3
months. Data was collected through the use of 7-point Likert-Items, Questionnaires, and
observation. Data was analyzed by using descriptive and inferential statistics and
through thematic analysis of qualitative data.
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RESEARCH CONTRIBUTIONS
Due to the limited research that focuses on designing technology to assist older
adults with over-the-counter medication information and the novelty of the interface
being design, the studies presented in this research are exploratory in nature. The
research therefore focuses on understanding and identifying challenges, examing how
technology might address the challenges, and conducting early stage evaluations of the
technologies designed and implemented to address those challenges in order to direct
future versions of the prototypes. The contributions of this research are therefore to:
1. Better understand older adults current over-the-counter medication selection
practices and challenges, and identify opportunities for technology to assist older
adults in the over-the-counter medication selection process. Limited to no
research exists that focuses specifically on designing technology interventions to
assist older adults with over-the-counter medication information. This research
builds on prior literature in HCI that examines the design of health technologies
that assists patients with medication related information. In a preliminary study,
opportunities were identified for technology to assist older adults with the OTC
medication selection process.
2. Conceptualize and design a novel interface for assisting older adults with OTC
medication information and examine the usability of the novel interface for
assisting older adults with OTC medication information. In the second phase of
the study, a novel interface was designed and evaluated for its potential to address
some of the challenges and barriers older adults face with OTC medication
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information. The usability and usefulness of the features of the interface were
examined and through this process, aspects of the design and technology features
that are useful for assisting older adults with OTC medication information were
identified.
3. Design a prototype translator that delivers simplified OTC medication
information to older adults and examine the effectiveness of the prototype
translator for affecting older adults control beliefs, comprehension, and
satisfaction of OTC medication information and identify opportunities to improve
the translator. In the final study presented in this dissertation, the feasibility and
effectiveness of a prototype translator was evaluated. Results of the study provide
insight on the feasibility of the technique for providing simplified information to
older adults. In addition, recommendations are provided for improving future
versions of the translator and similar techniques as well as suggestions for using
such techniques in consumer-based technology that assist older adults with OTC
medication.
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CHAPTER TWO
UNDERSTANDING THE OVER-THE-COUNTER MEDICATION NEEDS AND
PRACTICES OF OLDER ADULTS
DISCLAIMER: A version of this chapter was previously published by the author of this
dissertation (Martin, A.M., Jones, J.N., Gilbert, J.E. 2013. A spoonful of sugar:
Understanding the over-the-counter medication needs and practices of older adults. In
Proc. Pervasive Health 2013. 93-96.). The paper has been re-formatted for inclusion in
this dissertation. As a European Alliance for Innovation (EAI) endorsed transaction,
copies of the published paper are freely available with permission for sharing, adaptation,
and distribution under the terms of Creative Commons http://creativecommons.org/licenses/by/3.0/legalcode.

ABSTRACT
Understanding the needs of various stakeholders throughout the design process is
key for creating consumer health applications that are usable, effective, and useful for the
people that use them. This paper discusses the findings of an exploratory study aimed at
understanding the current practices, information needs, and challenges of older adults (65
years and older) when selecting over-the-counter (OTC) medication. The context of this
study lies in understanding older adults with the purpose of identifying opportunities for a
tailored consumer health application to assist them with selecting appropriate OTC
medications given their health history. This research contributes to the understanding of
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the current practices of older adults as related to OTC medication selection. In addition,
this paper provides a discussion of opportunities for future applications to help facilitate
this task for older adults.

INTRODUCTION
Each year, thousands die or are injured due to adverse drug events (ADEs)
resulting from taking medication [1, 2]. Medication interactions (ADEs resulting from a
reaction to a medication) are considered to be the main cause of ADEs [3]. To this end, in
recent years, several novel consumer health applications have emerged to support
consumers in managing or understanding medication information. In addition, these
applications have encouraged consumers to become more informed about the medication
they take.
This research builds on previous work by providing insight on the processes,
information needs, and challenges of older adults (65 years and older) when using overthe-counter (OTC) medication information to make a purchasing decision. OTC
medication use, compared to prescription, is heavily dependent on the consumer’s ability
to understand and correctly use the OTC medication given their knowledge of their own
health. Emphasis is placed on older adults because certain factors (e.g. lower health
literacy levels, risk of chronic illness) increase with age thereby increasing the risk of an
ADE [4, 5].
Although recent work has focused on understanding users in order to design
various consumer health applications for medication, little has been done to understand
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the specific needs of older adults in order to effectively communicate information for the
purpose of assisting them in the selection of an appropriate OTC medication. The
authors define an appropriate medication as one that does not conflict with a chronic
illness or other medication. The goal therefore of this exploratory study is to better
understand the current challenges and needs of older adults in an effort to identify
opportunities for a consumer health application to help facilitate this task.
RELATED WORK
Over the years, several researchers in the healthcare field have conducted studies
to understand users with the goal of improving user interactions with medication
information. In 1999, the Food and Drug Administration published the OTC Drug Facts
regulation as a guide for makers of OTC medication to follow [6]. That same year,
researchers released the results of a study examining users’ OTC Drug labeling format
preferences [7]. Following this study, several studies were published that focused on
different aspects of paper-based medication information design [7-10].
Similarly, researchers have used various techniques to better understand users with the
goal of designing consumer-based applications to assist with different aspects of the
medication regimen [11-19]. Seik and colleagues looked specifically at the needs of older
adults to understand the requirements for a personal health application to help them
manage medication [16]. Wilcox and colleagues examined the needs of cardiology
patients to design an in-hospital application to provide them with information about their
care (including medication and treatment) during their stay [17]. Neafsey and colleagues
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explored the needs of older adults to understand how to design an interactive educational
intervention to warn about OTC medication and alcohol interactions [18].
Although previous work in this area has provided insight on the needs of different
groups of users for different tasks related to medication, to the knowledge of the
researchers, no study has focused on understanding the needs of older adults when
attempting to select (opposed to manage) an OTC medication. This work builds on
previous literature by contributing to the understanding of older adults as related to
selecting an OTC medication. In addition, this research provides a discussion of
opportunities, based on the findings, for consumer health applications to assist in
communicating information about OTC medication to help facilitate the decision-making
process.

FIELD STUDY
The study was conducted on-site at two locations within the local community. A
research team member met and conducted meetings with administrators at each location
to explain the goals of the study, answer questions, obtain permission to recruit members,
and to obtain research site letters for the institutional review board (IRB) application.
Proper IRB approval was obtained before the study began.

Study Location and Participants
The study was performed at two locations: a senior life-long learning center and a
local senior activity center. Participants of the study were members of one of the two
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organizations. Participants were recruited by email or through a verbal announcement at
the center by one of the researchers. Participants in the study were required to be at least
65 years of age, purchase or select their own over-the-counter medication and have
purchased or selected for purchase at least one over-the-counter medication in the past
year.
A total of 10 participants were recruited for the study (female = 7, male = 3) with
ages ranging from 66 - 82 (mean = 74.2, S.D. = 4.685). Five participants were Caucasian
and five participants were African-American. One participant had a middle school
education, one earned a Master’s degree, and one earned a Ph.D. Most participants had at
least some college education (n=7).
All 10 participants indicated that they took medication (prescription and over-the
counter). When asked how many medications they take on a daily or weekly basis,
participant responses ranged from 3 – 12 (mean ~ 7). In addition, all participants
indicated that they had taken at least one over-the-counter medication within the last year
(min = 2 daily, max = 5 daily). All participants reported that they primarily purchased
their own OTC medication, however participants with a significant other reported that
their spouse would sometimes purchase OTC medication for them.

METHODS
Semi-structured interviews were conducted with participants. All interviews were
audio recorded and later transcribed for analysis. Data were analyzed for emerging
themes to create an initial coding guide. Two researchers met several times to discuss
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emerging themes and make updates to the initial coding guide. Researchers later used the
coding guide to independently and thematically code participant responses. The percent
of agreement among researchers was greater that 80% for all categories indicating a highlevel of agreement among coders.
Interview questions were designed to better understand some of the current practices and
challenges of older adults when choosing an OTC medication. These questions fit
broadly into the two categories detailed below.
1) Current OTC Selection Practices: OTC medication, unlike prescription, does not
require oversight from a healthcare provider and can be purchased at will by a
consumer [20]. It was important to get a sense of older adults’ attitudes towards
OTC medication selection. Participants were therefore asked questions to
understand their current selection process, the people involved, and the resources
they consult.
2) Challenges with OTC Medication Information: Questions in this category focused
on understanding some of the challenges older adults face when using OTC
medication information to make a decision to select or purchase.

Participants

were asked to describe any challenges they had with medication information in
the past year. Participants were also given examples of OTC medication
information (labels and page from WebMD) and asked to identify and discuss
anything they found cumbersome or helpful about the information or the
presentation of the information on the labels.
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FINDINGS
Participants’ responses to interview questions were categorized into high-level
themes based on the thematic coding of the interview data. In interviews, at a conceptual
level, participants described their current OTC medication selection processes. In this
process, older adults enter one or more states on their journey to selecting an OTC
medication (See Fig. 2-1). These states provide a basis for the information seeking
timeline. When searching for an OTC medication the older is either presented with
barriers that prevent them from identifying the benefits and risks of the OTC medication
or is faced with information needs or concerns that trigger a cycle in which the older
adult seeks information from information sources. In this cycle, if the older adult finds
the information presented challenging he or she may consult additional information
sources until an OTC medication is selected. Additionally, once the older adult has
selected an OTC medication to take, he or she may seek information regarding a
medication they have already selected. Each state in this process maps to one of the keythemes and is detailed below.
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Figure 2-1. Older adults’ over-the-counter medication selection process.

Information Seeking Timeline
Of the participants that mentioned that they sought information about their OTC
medications, some indicated that they would seek this information after first taking the
OTC medication. This was due to various factors including timing of scheduled visits
with their doctors or having taken the medication before. For example, four participants
mentioned that they felt comfortable asking their doctor about medications during regular
visits. P8 stated, “If I have any questions [about an OTC medication], I ask the
pharmacist and then at my next appointment with the doctor, I will ask the doctor.”

Barriers to Identifying OTC Medication Risks
The interviews revealed several potential barriers that may prevent older adults
from identifying OTC medication risks. One participant expressed his perception that
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OTC medications generally could not do much harm. He stated, “You have a feeling, if
you buy something over-the-counter, it’s probably not going to kill you. Right?”
Three participants mentioned that history or familiarity with a medication might
influence whether or not someone seeks advice about an OTC medication before
selecting. P1 stated, “The other thing is, if it’s a person who’s been around for decades,
and decades, and decades … and they’ve taken Advil their whole life, they’re just going
to grab a jar of Advil. You know, you sometimes develop an affinity for a certain pill
that’s over-the-counter”.
Finally, six participants indicated they were generally not interested or ignored
OTC medication information for various reasons. P6 stated, “I look at risks, but I sadly
have grown to the point of almost ignoring it because they list so many risk and it seems
though it’s mostly just for liability reasons”.

Information Needs and Concerns
Participants discussed several pieces of information they found important when
making a decision about taking an OTC medication. The top information need discussed
was medication use mentioned by eight of the ten participants. Medication use was
followed by interactions, mentioned by seven of the ten participants. At least two
participants discussed brand of medication, side-effects/risks, dosage
information/directions, ingredients, and price/cost each as important pieces of
information for making a decision to purchase a medication. One participant discussed
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expiration date and another the route (how the medication is administered) as an
information need.

Information Sources
Participants indicated a variety of information sources for learning about OTC
medications. Several participants expressed that they would consult a doctor or
pharmacist about an OTC medication. For example, when asked about the OTC
medication selection process, Participant 2 (P2) stated, “Well, if I am not sure, I just ask
the druggist [pharmacist]”. Additionally, P1 expressed concerns about asking the doctor
or pharmacist about an OTC medication. She stated, “They [the doctors] are so busy
now… The pharmacist is a little bit more available. I tend not to bother them if the store
is busy or something.” Several participants also mentioned consulting friends or family
(word-of-mouth) or using the OTC medication label.
Other participants mentioned using some type of technology to help them learn about an
OTC medication. For example, P5 stated, “Speaking for myself, I do have an app on my
pad that will give me the generic and the … What is it when it’s not generic, when there’s
a patented name?” However, when mentioned, the Internet was the primary source for
searching for medication information. Most participants however, did not cite a
technological source for learning about OTC medications. P1 provided an example of
how she searched for medication information on the Internet, but later stated, “When I’m
buying something over-the-counter, I usually don’t go into this great detail.”
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Challenges with OTC Medication Information
One of the most common challenges discussed with OTC medication information
was the layout and formatting of the OTC packaging labels. Eight of the ten participants
discussed challenges they had with either the size of the text or the organization of the
information. P4 expressed frustration when searching for the dosage on the OTC
medication packaging. He stated, “Where [is the] dosage? It’s not here. Okay, you got
to go on the other side and the dosage is buried in the middle of other things. ‘Stop and
ask your doctor if you vomit or something’. Well, I would like the directions [and] the
dosage to be right up front at the beginning.”
Another common complaint was with the language. Participants expressed that often
times they did not understand the information on the label which made it difficult to use.
P1 stated, “The other thing I see is a problem … I think they said, Don’t take this if you
are taking other drugs containing prescription or non-prescription NSAIDs… I wouldn’t
know what an NSAID is unless I Googled it”.
Participants also discussed challenges with the amount and kind of information
presented. P6 stated, “I think too that it’s so complex. There’s so much to try and read
and absorb off that label…”. He later suggested that some types of information were not
there or not apparent.

DISCUSSION AND CONCLUSIONS
The findings of this study provide a better understanding of the current practices
of older adults related to OTC medication selection and reveal several opportunities for
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technology to assist in this task. Although some participants in this study did not cite a
technological source for learning about their OTC medication, their non-use or nonadoption of current technology may be tied to the perceived benefit (i.e. usefulness) or
effectiveness of current technology for completing the targeted task [21].
For example, consistent with other studies, participants in this study expressed
challenges with the formatting and layout of OTC medication information [7-10].
Although prior research has produced guidelines for label formatting and layout,
understanding that font size is still a concern among older adults, presents the opportunity
for designers to provide technology that can address this concern (e.g. tools that provide
the same information with larger font) and highlight a benefit that is currently not address
through labeling.
Given that older adults are at greater risk for adverse drug events due to
medication, it is imperative that they are aware that there are potential benefits and risk
and upon this realization, that they can clearly see, find, and understand the information
provided to make an informed decision [4, 5]. A consumer health application therefore
has the opportunity to address some of the limitations of labeling, which may help better
support older adults in the process of selecting appropriate OTC medications.
Furthermore, careful technology design may also increase awareness of OTC medication
risks, which can incentivize the use of such technology among the older adult population
[21]. A discussion of opportunities is provided below.
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Technology to Support Language Simplification
Understanding health information is a challenge that is faced by many in the population
regardless of education level or expertise [4]. Participants of this study also expressed
challenges with understanding some of the medical terminology used on the label.
Technology may therefore be useful to bridge the gap between the required medical
terminology used on the label for accuracy and the layperson terminology desired by the
consumers for making a decision. Using plain language guides in the design or automated
techniques (e.g. text simplification) for simplifying language in the application may
greatly improve the usability of the information for any user, not just older adults.

Technology to Support Awareness
The findings of this study also imply that some older adults may not be aware of
the potential risks of OTC medication. Depending on the type of application being
developed, designers may also consider integrating elements of persuasion into their
applications. Persuasive technology design aims to change the attitudes and/or behaviors
of users through one of seven persuasion techniques: reduction, tunneling, tailoring,
suggestion, self-monitoring, surveillance, or conditioning [22]. Older adults in this study
mentioned challenges that can potentially be addressed by one or more of these
techniques. For example, reduction persuades by simplifying the steps a user takes to
complete a task. If the task of finding relevant information can be simplified through
technology design, older adults may change their attitudes toward seeking OTC
information in the future.
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LIMITATIONS AND FUTURE WORK
Though interviews were conducted until no new data emerged, the study is
limited by number of people interviewed. Further work is needed to determine if the
findings can be generalized to the larger population of older adults. Future studies will be
conducted to confirm the usefulness of the opportunities described and to further examine
ways of addressing the concerns through technology.
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CHAPTER THREE
DESIGNING AN OVER-THE-COUNTER CONSUMER DECISION MAKING TOOL
FOR OLDER ADULTS
ABSTRACT
Older adults are at increased risk of adverse drug events (ADEs) due to
medication and generally have more difficulty understanding health information. Health
information technology coupled with effective communication is thought to be beneficial
to improving many health related tasks. This paper describes the iterative design process
of a novel OTC consumer decision-making tool for older adults. Through expert review
and brainstorming, researchers designed a concept for a novel prototype system to help
older adults with OTC medication selection. In addition, older adults users were engaged
in user sessions to identify usability issues in the prototype system and to identify
features and functionality that might be useful in system designed to assist with over-thecounter medications. Nine usability issues were identified by 7 older adults in the current
design representing a probability of detection of .917. This study focuses on identifying
usability concerns in the initial design and features that older adults find beneficial for
selecting appropriate OTC medication. Finally, this paper presents a discussion of how
early stage usability evaluation helped to refine the design of the resultant technology.
Additionally, a discussion is presented of how early stage evaluation helped to revise the
model of how technology support mechanisms may be useful in the OTC decisionmaking process for older adults.
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INTRODUCTION
Communicating different types of health information to patients and consumers is
a huge concern in the public health community (Nielsen-Bohlm, 2004). Some healthrelated tasks, such as choosing an appropriate over-the-counter (OTC) medication, do not
require direct oversight from a health care provider, which increases the risk of potential
adverse events for the consumer (Covington, 2006; DeWalt, 2010). Therefore, it is
important for consumers to have sufficient health-related knowledge to lessen potentially
fatal events.
Thousands of hospitalizations and fatalities occur each year due to adverse drug
events (ADEs) caused by medication (DeWalt, 2010; Institutes of Medicine, 1999).
Unlike prescription medication, safe OTC medication use is heavily dependent on the
consumer’s ability to understand and use the OTC medication appropriately. In addition,
consumers view OTC medications differently than prescriptions and generally perceive
them as harmless (DeWalt, 2010). Although considerable research has been dedicated to
better understanding how to design “easy-to-read” labeling for medication, ADEs still
occur and older adults are at higher risk (United States Food and Drug Administration,
2009).
One approach to addressing challenges with communicating health information is
through health information technology (Healthy People2020, 2020). The design of
consumer-based health information technology to assist users with health related tasks is
a growing area within Human-Computer Interaction. Included in these health related
tasks are issues that surround the design of medication-related applications for varying
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groups of users. This research builds on prior work in this area by focusing specifically
on the design of technology to facilitate the consumer decision-making process when
selecting over-the-counter medication.

BACKGROUND
Consumers often misunderstand OTC or non-prescription medication information,
which contributes to the large number of adverse drug events occurring each year
(DeWalt, 2010; Institutes of Medicine, 1999). There are nearly one hundred thousand
medications available over-the-counter (Rolita & Freedman, 2008). Older adults account
for nearly 40% of all over-the-counter medication use and use twice as many over-thecounter medications than prescription medications (Conn, 1992). On average, older
adults take 6-9 medications concurrently placing them at a higher risk for ADEs. In
addition to taking more medication, older adults also tend to have lower health literacy
levels and are at increased risk for chronic illness, which also contributes to a higher risk
of adverse drug events (Nielsen-Bohlm, 2004). Health literacy or the “degree to which
an individual has the capacity to obtain, process, and understand basic health information
and services needed to make appropriate health decisions” is noted throughout literature
as a contributing factor to the success of health communication efforts (Nielsen-Bohlm,
2004; Warner, Menachemi, & Brooks, 2006). Adequate health literacy is also central to
favorable health outcomes (Nielsen-Bohlm, 2004; Warner, Menachemi, & Brooks, 2006).
Adults 65 years of age and older tend to have on average lower health literacy levels than
adults younger than 65 (Nielsen-Bohlm, 2004).
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Many factors affect a person’s ability to understand health information (NielsenBohlm, 2004). Among these factors is the way health information is presented to the
consumers. For older adults, one of the primary challenges with OTC medication is the
size of the font used on the labels (Martin, Jones, & Gilbert, 2013; Watanabe, Gilbreath,
& Sakamoto, 1994; William & Wogalter, 1999). However, formatting, information
order, external tag placement, and language used may also influence how well OTC
medication labels communicate information to consumers (Klein & Issacson, 2003;
Morrow, Weiner, Young, Steinley, & Murray, 2003; Rolita & Freedman, 2008;
Watanabe, Gilbreath, & Sakamoto, 1994; William & Wogalter, 1999).

RELATED WORK
In the area of Human Computer Interaction (HCI), research that focuses on the
design of consumer-based Health Information Technology (HIT) is a growing area of
concentration. The main emphasis of HCI is to design technologies from a user-centered
standpoint to improve the usability of those technologies. The goals of usability are to
ensure that technologies are effective, efficient, safe, have good utility, are easy to learn,
and easy to remember (Preece, Rogers, & Sharp, 2007). One tenant of HCI is to
approach the design process with the user’s needs in mind (user-centered design) in order
to develop technologies that meet the goals of usability. This tenet is well situated for
consumer health applications where the consumer’s information needs are important to
the success of the application.
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Consumer-Based Technologies for Communicating Medication Information
Within the area of HCI, approaches to designing consumer-based technologies are
wide ranging and address a wide range of issues in healthcare, including helping
consumers with medications. These technologies can be roughly divided into two
groups: Health Interfaces and Applications and Physical Devices. However, the groups
often overlap. Prior research on consumer-based technologies involving medication
provides a foundation for this research and therefore an overview of current trends is
provided.

Health Interfaces and Applications
The popularity of the Internet, mobile devices, and other technologies have
prompted research within HCI that focuses on designing personal health applications and
interfaces to aid consumers in managing their prescription and OTC medications.
Making use of mobile devices, personal computers, and other forms of technology, prior
research has tackled several of the healthcare concerns surrounding patient or consumerbased medication practices.
One growing body of research focuses on designing medication compliance and
management systems to remind patients to take medications and of dosage (Bickmore &
Jack, 2009; Bickmore, Mauer, Francisco, & Brown, 2008; Hoogendoorn, Klein, &
Mosch, 2008; Khan, Siek, Meyers & Haverhals, 2010; Qudah, Leidekkers, & Gay, 2010;
Rodrigo, Cherubini, & Oliver, 2010; Seik et al, 2011; Seik et al, 2010; Silva, Moutthan,
& Saddik, 2009). These applications are designed from a patient’s perspective with the
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goal of improving usability and thereby promoting usage. Each of these applications
have varying designs, but they provide the ability for patients to set reminders, enter
dosage, create medication lists, and/or check potential interactions. Another body of
work focuses on helping patients or consumers better understand medications and
treatments.
Wilcox and colleagues through participatory efforts, designed personal health
applications and in-hospital displays to provide hospital patients with information
regarding their hospital care during their stay (Wilcox, Morris, Tan, Gatewood, &
Horvitz, 2011). Interviews with physicians, nurses, and patients were conducted to
determine the medication information that was important to share with patients
throughout their stay. One aspect of this work focuses on providing patients with “microexplanations” of the medications they are prescribed and treatments administered while
in the hospital (Wilcox, Morris, Tan, Gatewood, & Horvitz, 2011).
Another area of research focuses on designing instructional training systems for
patients and consumers regarding medication practices. The goal of these applications is
to teach users about a particular medication, medication regimen, or medication risks.
Neafsey and colleagues designed an interactive educational intervention to help active
older users understand OTC medications and alcohol interactions (Neafsey, Strickler,
Shellman, & Padula, 2001; Neafsey, Strickler, Shellman, & Chartier, 2002). Using
touchscreen notebook computers, the goal of this research was to increase older adults’
knowledge of the potential drug interactions between prescription medications; and OTC
drugs and alcohol (Neafsey, Strickler, Shellman, & Padula, 2001; Neafsey, Strickler,
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Shellman, & Chartier, 2002). To address this goal, the researchers created the Personal
Education Program (PEP), an interactive multimedia computer software program that
nurse practitioners provided for patients on visits. Results of this study suggest that users
of PEP demonstrated a greater self-efficacy or confidence to avoid the adverse
interactions presented by PEP.

In addition, both users of the control group and of PEP

were highly satisfied with PEP and indicated that they planned to make changes in selfmedication behavior after using PEP (Neafsey, Strickler, Shellman, & Padula, 2001;
Neafsey, Strickler, Shellman, & Chartier, 2002).
Health dialog systems are another form of interface for communicating
medication information. A health dialog system is roughly defined as any computational
system that facilitates communication between a computer and a user (Bickmore &
Giorgino, 2006). A simple example of a dialog system is a wizard that guides a user
through the task of installing some software. This communication generally involves
input from the users (e.g. voice, gestures, text, touch) and output from the computer
system (e.g. spoken language, text). Timothy Bickmore describes one example of how
dialog systems can be used to facilitate medical information to patients. Bickmore and
colleagues designed a virtual nurse agent to help instruct low health literacy hospital
patients about their post-hospital care regimen including their medication regimen
(Bickmore & Giorgino, 2006; Bickmore & Jack, 2009). The virtual agent and system
design was informed by the results of UCD process through ethnographic studies,
interviews with nurses and patients, and usability testing. As a result the overall
satisfaction level of the virtual nurse was high (94%) (Bickmore & Giorgino, 2006).
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Physical Devices
Research aimed at helping consumers understand medication information is not
limited to interface design. Physical devices designed to help patients comply and
manage medication regimes are growing in the area of ubiquitous computing.
Researchers at the Center for Strategic Technology Research presented a concept of a
Magic Medicine Cabinet that communicates allergy information and potential
interactions to users by examining RFID smart labels (Wan, 1999). Similar devices
including a “Smart Drawer” and a portable medicine dispenser were created using usercentered design principles to aid individuals in medication management and compliance
(Becker et al, 2009; Beer, Keijers, Shahid, Abdullah, & Mubin, 2010).
Researchers at the University of Baja California designed three ubiquitous
computing devices (Remind-Me, Guide-Me, and Care-Me) to assist elderly individuals
with medication management and compliance. Remind-Me was designed to prompt
elderly users to take their medications. Guide-Me provides elderly users with dosage
information. Care-Me was designed to make elderly individuals aware of the importance
of completing medication regimes despite how they may feel (Vazquez, Rodrigues, &
Andrade, 2010). Similarly, research concentrating on health monitoring sensor networks
aims to improve upon existing reminder systems tracking to detect the time, amount, and
manner in which a medication was taken and alert a patient to stop the regimen when
adverse events occur (Evers, Wildvuur, & Krose, 2010; Lee & Dey, 2011).
Building on prior literature, this research proposes that technology designed to
assist older adults during the process of selecting an OTC medication may also be
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beneficial to improving understanding and awareness of OTC medication information for
older adults. Currently, there is limited research that focuses on how technology can be
designed to help older adults navigate the decision-making processes of selecting OTC
medication.

Management, Compliance, and Consumer Decision-Making
Much of the literature dedicated to the design of medication related technology,
has focused on medication management or compliance, which although related
somewhat, is different from the task of consumer decision-making. Managing a
medication regimen can be a complex task especially for older adults (Marek & Antle,
2008; Seik. Khan, Ross, Haverhals, & Meyers, 2011). At a high-level medication
management can include any tasks related to buying, taking, and understanding various
medications (Marek & Antle, 2008). However, each task presents its own set of
challenges. Oftentimes medication management applications are designed to meet one or
all of the tasks related to medication management. For example, the design of a
compliance application or devices typically focus on monitoring whether or not a patient
has taken his or her medication and whether or not that medication was taken on
schedule. Other applications focus on helping patients to schedule medications and/or
prescription refills by providing users with the ability to create lists to document
medications, pharmacist, physicians, and alarms/alerts to help them comply with a
particular regimen. However, little guidance is available on how to design medication
applications that focus on helping consumers to make a decision about a medication.
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Consumer decision-making is concerned with “how consumers develop and use strategies
for making decisions, how different amounts of prior knowledge influence consumer
choice processes, how consumers adapt to different decision strategies, and how
consumers categorize products”(Bettman, Johnson & Payne, 1991). Further, Bettman
and colleagues describe a consumer decision-making task as an intricate set of factors
that requires a consumer to consider the number of alternatives available, attributes of
value, uncertainty, availability of information in terms of environment and content, and a
variety of other factors (e.g. importance of the task- what are the consequences of making
the wrong decision).

In the case of OTC decision-making, there are thousands of OTC

medications available on the market (hundreds of alternatives) with different attributes of
values (risks, warnings, dosages, ingredients, etc.) that present tradeoffs. In the pharmacy
(environment) the label provides one source of in-environment information. The
pharmacist is also a good in-environment information source. The content provided by
the label and pharmacist can also provide consumers with additional information about
tradeoffs of attribute values (e.g. risks, warnings). However, oftentimes these sources are
underutilized due to other factors. For example, the small print on the label has found to
be a challenge for consumers especially the older adult population (Klein & Issacson,
2003; Martin, Jones & Gilbert, 2013; Warner, Menachemi & Brooks, 2006). Similarly,
understanding health terminology can be challenging and may impact how consumers are
able to comprehend the OTC medication label (Nielson-Bohlm, 2004; Martin, Jones &
Gilbert, 2013). Therefore, the OTC consumer-decision making task can become
complex. This research therefore extends, previous research on the design of consumer-
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focused or patient-focused medication applications by exploring the design of a novel
consumer-decision making tool to assist older adults in this task. To the author’s
knowledge, no such technology currently exists that focuses specifically on supporting
older adults’ OTC decision-making. This research describes the iterative design process
employed to conceptualize, design, and evaluate a novel interface to assist older adults in
the task of selecting appropriate over-the-counter medication.

STUDY OVERVIEW
An exploratory study was conducted to conceptualize and design technology that
could assist older adults in OTC consumer decision-making. A combination of expert
review and user sessions with older adults were used to identify tasks, information needs,
features, functionality, and aspects of the look-and-feel that were important and useful to
the task of OTC consumer decision making. The preliminary design of the prototype was
informed by previous literature on design for older adults and the results of a previous
study. The preliminary prototype was then evaluated through rounds of expert review.
Following, older adults evaluated the prototype for usability flaws and discussed features
and functionality that they feel would be helpful in the task of selecting appropriate OTC
medications.

METHODS
An iterative design process was used to conceptualize and design a preliminary
prototype (See Figure 3-1). This study is part of a larger Exploratory-Sequential Mixed

34

Method study (Creswell, 2013) and each phase of the study was used to inform the next
phase. The results of a preliminary study, and literature on design for older adults and
design of medication related applications were used to develop preliminary prototypes.
Expert reviewers met to discuss preliminary prototype designs, evaluate the designs
based on their knowledge of design principles and design for older adults, and examine
how well the prototype might facilitate the task of OTC consumer decision-making. In
addition, older adults were engaged in participatory user sessions to better understand
features and functionality that might be useful in the task OTC consumer decisionmaking. Participants also provided feedback on any concerns with usability or ease of
use.

Figure 3-1. Iterative Design Process

Preliminary Prototype Design
Two researchers met over the period of 2.5 months to brainstorm preliminary
prototype ideas and evaluate the potential for the prototype to facilitate the task of OTC
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consumer decision-making for older adults. For the initial prototypes, the researchers
goals were to explore different ways to address the challenges identified in literature and
in the preliminary study (See Table 3-1). Nielsen’s Usability Heuristics were used to
guide reviews of the system (Nielsen, 1994). Prototypes ranged from low-fidelity (paperbased mock-ups) to high-fidelity (PowerPoint decks that included simulated interactions).
Overall, the researchers aimed to design a persuasive interface. Prior research indicates
that many times consumers are unaware of OTC medication risks and may need support
when navigating OTC medication information (DeWalt, 2010; Martin, Jones & Gilbert,
2013). This implies that a persuasive design may be able to address some of the
challenges and barriers faced by older adults. The preliminary design therefore included
aspects of persuasive technology design that could potentially address those challenges.

Initial Design Goal
Support for Medical Terminology

Tailored Design for Older Adults

Description/Reasoning
Prior research indicates that consumers, in
particular older adults, may have trouble
understanding and acting upon health
information (Hanchate, Ash, Garmararia &
Paasche-Orlow; Nielsen-Bohlm, 2004;
Warner, Menachemi & Brooks, 2006). In
addition, in interviews with older adults,
participants identified that they found some
terms included on the OTC medication
label challenging.
Research on the design of medication
packaging indicates that formatting and
layout are important factors in how
consumers use medication information
(Klein & Issacson, 2003; Morrow, Weiner,
Young, Steinley, & Murray, 2003; William
& Wogalter, 1999). Older adults also
indicated that formatting such as font-size
might hinder them from using OTC
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medication information to make decisions
(Martin, Jones & Gilbert, 2013).
Therefore, the design was tailored by
focusing on formatting, layout, and
information needs that may be useful to
older adults.
Another design goal was to look at
technologies that could be accessed by
older adults who may or may not currently
have access to a computer at home or a
mobile smart device. The rationale for this
is to provide access to technology for a
group of older adults who may be curious
or could be persuaded to use technology
even though they may not have personal
access for searching for information about
medication at home or otherwise.

Access to Technology

Table 3-1. Initial Design Goals
Persuasive Technology Design
Fogg presents two approaches to designing persuasive systems: Macrosuasion and
Microsuasion (Fogg, 2002). Macrosuasion is used to describe systems in which
persuasion and/or motivation are the singular intent of the product. For example, if a
system is designed with the sole intent of promoting or motivating a certain behavior. On
the other hand, products that are designed with microsuasion in mind do not have an
overall intent to persuade but instead incorporate persuasive elements to achieve some
other goal. Because the overall intent of the system being designed is to assist older
adults with OTC decision-making, the microsuasion approach was taken by integrating
varying persuasive technology tools into the design of the system. Fogg defines
persuasive tools as an “interactive product designed to change attitudes or behaviors”.
Seven types of tools have been identified including: Reduction, Tunneling, Tailoring,
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Suggestion, Self-monitoring, Surveillance, and Conditioning. Three of those tools were
applied to the design of this system and are described below.

Reduction
Reduction (persuasion through simplifying) focuses on making complex tasks
simpler (Fogg, 2002). The premise behind reduction technology is that by making target
behaviors easier, one can increase the benefit/cost ration of performing the behavior
because humans seek to minimize costs and maximize gains. Reduction can be
implemented by minimizing the number of steps it takes to complete a task. One
example provided by Fogg is Amazon “one-click” shopping. The argument is that
because the number of steps to purchase “thing A” is reduced, consumers will be more
motivated to buy “thing A”. For the purposes of this research, simplifying was integrated
into the prototype by providing support for medication terminology. Prior research in
healthcare has identified health literacy as a potential barrier to understanding health
information. In addition, in a formative study, older adults identified “complex medical
terms” as a potential barrier to using OTC medication information. By providing support
for simplified information in the system, the goal was to reduce the number of steps and
time needed to understand the information.

Tunneling
Tunneling (guided persuasion) motivates by leading users through a set of steps
to some goal (Fogg, 2002). The premise behind tunneling is that it makes it easier to go
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through the process because the designer controls what the user experiences and also
supports them through the process. Similarly, tunneling provides consistency, and it is
believed that once a person commits to something, he or she will most likely follow
through. In the prototype, the system guides the user through the process of determining
whether or not an OTC medication was appropriate. The initial interface was designed to
guide a consumer through the information, highlighting information that should be
considered in OTC decision-making process, and supporting the user through the process
by providing access to streamlined and simplified information.

Tailoring
A tailoring (persuasion through customization) technology provides users with
relevant individualized information to users to change their attitudes and/or behaviors
(Fogg, 2002). The premise behind tailoring is to make the task simpler by highlighting
information that is relevant to the individual. Tailored information has been found to be
more effective than generic information at changing attitudes and behaviors. The initial
prototype was designed to provide tailoring through a custom interface designed for older
adults and through custom information and/or recommendation to the consumer based on
the input he or she provided to the system.

Brainstorming and Review: Round I
The first two mockups were designed as search interfaces that augmented the
information provided on the OTC medication label. In Mockup A, after typing in a
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medication name and searching for a medication the user would be presented with a
tabbed interface that provided information about the medication (See Figure 3-2).
Mockup B took and more informed approach where users could enter information about
any chronic illnesses or prescription medication they may have. The system would
customize information based on their input. Users would also be presented with a code
on their first use so that they could bypass some steps in subsequent interactions with the
system (See Figure 3-3). By including information on illnesses and prescription
medication, users, in addition to the augmented information, would be provided with
alerts that notify them of a potential adverse interaction.

What(OTC(medication(would(you(like(to(learn(more(about?(

You$would$like$to$learn$more$about$Allergy1.$$Is$that$correct?$

Allergy1(

Yes$

No$

Submit(

Can+I+help+you+9ind+something?+
Submit+
Description+

Purpose+

Uses+

Warnings+

Dosage+
Instructions+

Inactive+
Ingredients+

Warnings:+
Helpful+Hint:++Be+sure+to+also+check+the+active+and+inactive+
+
ingredients+sections+which+may+also+contain++ingredients+
that+can+cause+an+interaction.+!
Ask+a+doctor+before+use+if+you+have+
• glaucoma+
• a+breathing+problem+such+as+emphysema+or+chronic+bronchitis+
• trouble+urinating+due+to+an+enlarged+prostate+gland+
An+eye+condition+that+leads+to+eye+damage.+
As+a+doctor+of+pharmacist+before+you+use+if+you+are+taking+
• tranquilizers+or+sedatives+
When+using+this+product+
• you+may+get+drowsy+
• avoid+alcoholic+beverages+
+

Figure 3-2. Mockup A – Search Interface with Augmented Information
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Do$you$currently$have$an$chronic$illnesses?$$For$example,$diabetes,$
high;blood$pressure,$or$heart$disease?$

Okay.**Please*type*your*chronic*illnesses.**One*at*a*time.*
High%Blood*Pressure*

Yes$

No$

Submit*

Skip$

Enter$user$code$

Can!I!help!you!Cind!something?!
Submit!
Description!

Submit&

Sugar&

Uses!

Warnings!

Dosage!
Instructions!

Inactive!
Ingredients!

!
!
!
Your!unique!code!is:!333.!!You!can!use!this!code!to!bypass!typing!chronic!illness!
!
and!medication!information!in!the!future.!If!your!information!changes,!you!can!
!
update!your!code!by!repeating!the!process.!
!
!
Done!
!
Brand!Name:!Generic!Allergy!1!
Medical!Name:!!Allergy!1!
Description:!!Allergy!1!is!a!medication!for!allergies.!
Other!Brands:!!Allergy!2,!Allergy!3!
!

Okay.&&Please&type&your&chronic&illnesses.&&One&at&a&time.&

High9blood&pressure&

Purpose!

X
X
Done&

Can+I+help+you+9ind+something?+
Submit+
Description+

Purpose+

Uses+

Warnings+

Dosage+
Instructions+

Inactive+
Ingredients+

Active+Ingredient:++
Diphenhydramine+HCI+25+mg+
Purpose:++
Antihistamine+
+
A+drug+to+relieve+a+cold+or+allergy+by+blocking+
histamine,+something+that+causes+allergies.+

Medications+containing+antihistamine+may+not+be+appropriate+for+people+with+
highIblood+pressure+or+taking+highIblood+pressure+medications.++Please+consult+
your+doctor+or+pharmacist+before+taking+this+medication.+

Figure 3-3. Mockup B –Search Interface with Customized Augmented Information
Protocol
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Evaluation: Round I
Both mockups were designed to be presented on a multimodal kiosk and provide
touch input and visual and audio output. Two HCI researchers evaluated mockups for
their potential for assisting older adults with OTC consumer decision-making. Although
the prototypes addressed several of the initial design goals, researchers identified several
usability concerns.

•

Input method – Typing (Flexibility and Efficiency of Use)
Although typing allows users to freely search for any OTC medication, reviewers
agreed that there might be issues with knowing how to spell certain medications.
In addition, because the device was being designed for in-pharmacy use, there
were concerns with the amount of additional time typing would add to the task at
hand.

•

Amount of Information Presented & Not Enough Guidance (Aesthetic and
Minimalist Design)
Tabs were added to provide formatting and to delineate the OTC medication
information presented by the mockup. Although, this reduced the amount of
information presented to the user by some degree, the results of the review
revealed that additional guidance might be beneficial for older adults. The
mockup presented the medication information with settle alerts about things to
consider. However, because oftentimes consumers are not aware of the risk of
OTC medication (DeWalt, 2010), it was decided that the mockups needed more
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guidance and support to make consumers more aware of things they should
consider in their decision-making process. Additionally, it was decided that the
alerting mechanism was not pronounced enough considering the purpose of the
technology is to alert older adult of potential risks.
•

Privacy vs. Intelligence (Special Considerations)
The trade-off between privacy and intelligence was key concern in the
conceptualization of the initial mockup. Because the idea was that the technology
could be accessed in the pharmacy, the researchers were concerned with asking
users to input information in a public place and also the potential storage of that
data. Mockup A approached the challenge by not asking users for any personal
information. It was designed to only provide information about a selected
medication and “hints” about potential risks. Mockup B was designed to allow
users to type in their current medications and illnesses and the user was then
provided with a code they could use to bypass these questions in subsequent visits
to the system. The mockup would then provide personalized alerts of potential
risks a user might have. After reviewing the two mockups, it was decided that
neither approach A nor B was ideal. Therefore, the researchers agreed that a more
seamless approach to providing customization while considering privacy was
needed. This concern was revisited in successive designs.
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Brainstorming and Review: Round 2
Following the first round of brainstorming and review, a second set of prototypes
was designed to address the concerns identified in the first review (See Figures 3-4 & 35). Two prototype versions were designed. Both were designed as multimodal systems
that allow touch input and provided both visual and audio output. The first version was
designed as a recommender system. Users could choose conditions they had and/or
medication they were taking and the system would provide a recommendation of whether
the medication was appropriate. Additionally, alternative designs were created that
included recommendation of other medications that may be appropriate. The second
version of the prototype was designed to provide the user with information only. In this
version, the system would alert users of any medical conditions and/or medications that
might interact with the medication. The following changes were implemented to address
the concerns identified in the previous review:
•

Input Method – Barcode Scanner
First, informed by prior work (Seik et al, 2011), a barcode scanner was included
in the design as an input method to eliminate the need for typing. By including a
barcode, users were not required to remember the spelling of medications and the
amount of time it takes a user to complete a task may be reduced.

•

Guidance and Amount of Information
To reduce the amount of information presented to the user, information on the
medication was limited to benefits and potential interactions with medical

44

conditions and medications. The interface was re-designed to be more persuasive
and to guide users through the process while highlighting important information.
•

Privacy vs. Intelligence
To address the trade-off between privacy and intelligence, the new design
included a degree of customization that did not require users to input information
about illness and medications directly. Instead of asking users to directly enter
information on conditions and medication, the system would suggest potential
illness and medication interactions with the medication. Users could then select
any options that apply to their case and the system would use this information to
provide recommendation about whether or not the medication may be safe to take.

Main	
  Navigation	
  Sequence	
  

WELCOME'
Ac#ve&Ingredient:&DIPHENHYDRAMINE&

PLEAE'SCAN'THE'MEDICATION'
TO'BEGIN'

NEXT&

45

DO(YOU(CURRENTLY(HAVE(ANY(OF(THE(
FOLLOWING(CHRONIC(ILLNESSES?(
(SELECT(ALL(THE(APPLY)(

TROUBLE(URINATING(DUE(TO(AN(ENLARGED(
PROSTATE(

This%medica+on%temporarily%relieves%these%symptoms%due%
to%hay%fever%or%other%upper%respiratory%allergies:%
• Sneezing%
• Runny%nose%
• Itchy,%watery%eyes%
• Itchy%throat%

BREATHING(PROBLEM(SUCH(AS(EMPHYSEMA(OR(
CHRONIC(BRONCHITIS(
GLAUCOMA(

NEXT%

NEXT(

	
  

PLEASE&TALK&WITH&YOUR&DOCTOR&OR&PHARMACIST&
BEFORE&TAKING&THIS&MEDICATION.&&

DONE&

	
  
Alternative	
  Recommendation	
  Screen	
  

PLEASE&TALK&WITH&YOUR&DOCTOR&OR&PHARMACIST&
BEFORE&TAKING&THIS&MEDICATION.&&
Aisle:'1A'
Price:'$6.99'

Aisle:'1A'
Price:'$12.99'

Aisle:'1A'
Price:'$19.99'

VEIW&ALTERNATIVE&MEDICATIONS&
NO&THANK&YOU&
DONE'

	
  
Figure 3-4. Recommender System Prototype
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WELCOME'
Ac#ve&Ingredient:&DIPHENHYDRAMINE&

PLEAE'SCAN'THE'MEDICATION'
TO'BEGIN'

NEXT&

TALK%TO%YOUR%DOCTOR%OR%PHARMACIST%BEFORE%
TAKING%THIS%MEDICATION%IF%YOU%TAKE%THE%
FOLLOWING%MEDICATIONS.%
SEDATIVES%OR%TRANQUILIZERS%–%A%DRUG%THAT%CALMS%

This%medica+on%temporarily%relieves%these%symptoms%due%
to%hay%fever%or%other%upper%respiratory%allergies:%
• Sneezing%
• Runny%nose%
• Itchy,%watery%eyes%
• Itchy%throat%

ANY%PRODUCT%CONTAINING%DIPHENHYDRAMINE%–%A%
DRUG%THAT%TREATS%ALLERGIC%REACTIONS%OR%MOTION%
SICKNESS%

NEXT%

DONE%

Figure 3-5. Information System Prototype

Evaluation: Round II
A review of the updated prototypes yielded several additional usability concerns.
First, one reviewer mentioned based on his experience designing touch-based interfaces
that include checkboxes, that the design of the checkboxes may be a problem
(Consistency and Standards). The design was therefore updated to remove obvious
checkboxes (See Figure 3-6). Second, there was concern for how the consumer-friendly
information was presented (Match Between System and the Real World). The prototype
was updated to include links to consumer-friendly language. This approach allowed us to
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provide the option without altering the original information. It was also decided that a “I
AM NOT SURE” option should be included in the list of medications and conditions
presented to the user to minimize the risk that the user may get stuck if none apply (Error
Prevention). Similarly, a “Back” and “Cancel” button was added to each screen to allow
the users to go back without restarting the process and to provide an exit if needed (User
Control and Freedom). Finally, coloring was added to the final screen to provide
additional notification of the system’s recommendation (Visibility of System Status).
There was some also concern with links being displayed on a button. However, it was
decided to test the concept with users to get feedback.
Page#
5#of#6#

Do#you#have#any#of#the#following?#
(Touch#All#That#Apply)#

!
!
A!breathing!disease!caused!by!inﬂamed!tubes!in!the!throat.!

Trouble#Urina;ng#Due#to#an#Enlarged#Prostate#

Breathing#Problem#Such#as#Emphysema#or#Chronic#Bronchi;s#

Glaucoma#
I#Am#Not#Sure#

Back#

Cancel#

Next#

This%medica+on%may%not%be%appropriate.%Please%
talk%to%your%doctor%or%pharmacist%before%taking%it%or%
ask%them%about%one%of%the%following.%

Aisle:%1A%
Price:%$6.99%

Aisle:%1A%
Price:%$12.99%

Based&on&the&informa/on&you&
provided,&we&did&not&ﬁnd&any&
poten/al&interac/ons.&
&
If&you&are&s/ll&unsure,&please&talk&
with&your&doctor&or&pharmacist&
before&taking&it.&

Aisle:%1A%
Price:%$19.99%

Done%

Done&

Figure 3-6. Prototype Updates
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In addition to the minor usability concerns, there was still concern about the
amount of medication information included in the prototype (Aesthetic and Minimalist
Design). Therefore, based on a prior study, the prototype was updated to include all
information included on OTC medication level, but to be presented to the user in chucks
based on topic (i.e. Inactive Ingredients, Purpose) instead of all at once.

User Sessions with Older Adults
Following the expert review, the preliminary prototype was evaluated with older
adults to obtain additional feedback on the usability of the prototype and learn about
features they find useful to assist with the OTC consumer decision-making task. Because
the focus of the technology is a consumer-decision making tool that can be used
independently by an older adult consumer, participants were purposefully recruited to
meet several criteria. Participants were required to be 65 years of age, purchase or select
their own OTC medication, and have purchased or selected at least one OTC medication
within the past year.
Seven older adults volunteered to participate (female = 3, male = 4). Participants’
ages ranged from 65 – 75 (mean = 70, S.D. = 3.1). Three participants were Caucasian
and four participants were African-American. All but two participants had at least some
college education and all but one participant was retired. Most participants reported
taking at least one over-the-counter medication per week. One participant took OTC
medication every 3 – 4 months. IRB approval was obtained before the study began.
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Individual sessions with older adults were conducted on-site at two locations that
serve older adults populations. During a session, the participant was presented with a
mixture or low-fidelity and high-fidelity paper-based prototypes of an OTC consumer
decision-making technology. Participants were then provided with a verbal scenario and
were asked to interact with the prototype and walk through an OTC decision-making
task. The scenario involved a fictional adult that was 65 years old and with a list
conditions/diseases and medications. The prototype was presented to participants on an
iPad device. The design was informed by previous literature on design for older adults
and expert review. It mimicked a partially functioning touch-based interface and
simulated text-to-speech by speaking the words presented on the screen. It guided
participants through the task of navigating the OTC medication information (See Figures
4-6).
Once the participants finished interacting with the prototype, they were asked a
series of questions in the form of a semi-structured interview. Interview questions
centered on several broad categories including: overall like or dislike of the prototype;
motivations for use; ease of use; language; guidance; trust; and amount of information
provided. The primary role of the prototype was to act as a technology probe (Hutchinson
et al, 2003) and discussion point to elicit conversation on the usefulness of the features
during the interview session. In addition, several alternative paper-based mock-ups were
used in the interview to encourage discussion of features that were not included in the
simulated prototype, but were being considered for inclusion by the researchers. The
purpose of the alternative mock-ups were to elicit discussion on what additional features
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participants felt were needed but not included in the current design or features that could
be removed. Therefore, the design sessions were not iterative and each participant
viewed the same prototype throughout the duration of the study. In addition to responses
to interview questions, feedback was also collected through observation and direct
response from participants on any usability and design concerns.

FINDINGS: USABILITY AND DESIGN CONCERNS
A total of 9 usability issues were identified during the study (See Table 3-2). Of
the 9 usability issues that were identified 3 were identified by over half of the participants
in the study. A usability issue was defined as anything that prevented the user from
finishing the task at hand (Tullis and Albert, 2008). This included anything that caused
confusion, not seeing something that should be noticed, not understanding the navigation,
and/or misinterpreting content. During the study, participants were observed and
potential usability issues were recorded on printouts of the system’s interface. The
researcher considered both verbal and non-verbal expressions made by the participant
when interacting with the system that might point to usability issues. In addition,
usability issues described in the interview transcripts were analyzed and coded.
Each of the 9 usability issues were rated based on severity to the overall design of
the system. A high severity task is any issue that leads to task failure (Tullis and Albert,
2008). Two issues were rated as high severity 1) It was not clear how to move to the next
step in the system and 2) It was not clear how to begin using the system. Although the
tasks rated with high severity may not lead to task failure, they may deter use of the

51

system or prevent users from completing task. Two tasks were rated as medium severity.
Medium severity tasks contribute to task failure but do not directly prevent task failure
(Tullis and Albert, 2008). All other tasks were rated as low severity due to the small
percentage of participants that identified the issue and/or its overall impact on the system
design.
Usability Issue

Description

Issue 1

Participant mentioned that
inactive ingredients are not
necessary and viewing them
should be optional.
It was not clear how to move to
the next step in the system.
Once the system has found one
possible interaction, there is no
exit and the user must finish all
steps before getting to the final
screen.
It was not clear how to begin
using the system.
Participant had trouble selecting
buttons that listed conditions or
medications that might interact
with the medication.
Participant did not notice links to
additional information about
medical terms.
Participant could not turn off
speech completely.
Participant could not hear voice
user interface even at the highest
volume setting.
Participant attempted to navigate
the system using his or her voice,
although speech recognition was
provided.

Issue 2
Issue 3

Issue 4
Issue 5

Issue 6
Issue 7
Issue 8
Issue 9

Number of
Unique
Instances
4

Number of
Participants that
Experienced Issue
2

Severity
Rating

9

4

High

2

2

Low

6

6

High

6

3

Medium

6

5

Low

2

2

Low

5

5

Medium

2

1

Low

Table 3-2. Usability Concerns
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Low

Typically, five participants is recommended for usability testing as nearly 80% of
usability issues are thought to be observed with the first five participants (Lewis, 1994;
Nielsen & Landauer, 1993). Because, this is an early stage usability test on a novel
system design, seven participants were recruited to help to refine the design. Data
gathered from the seven participants reveal that the overall average proportion is 0.49,
which is the overall probability rate for the test (See Table 3-3). The probability of
detection is therefore 0.991. This suggests that ~99.1% of the usability issues found
would be identified with a sample of seven users (See Figure 3-7).
Participant
P1
P2
P3
P4
P5
P6
P7
Proportion

Issue
1

Issue
2

X

X

X
X
X
0.57

X
X
X
0.57

Issue
3

X

Issue
4
X
X
X
X
X

Issue
5

X
X

X
0.29

X
0.86

0.29

Issue
6
X
X

X
X
X
0.72

Issue
7

X
X
0.29

Issue
8
X
X

X
X
X
0.72

Issue
9
X

0.14

Proportion
0.33
0.67
0.11
0.33
0.67
0.67
0.67
0.49

Table 3-3. Average proportion of usability issues found

•
•
•
•
•

Probability	
  of	
  Detection	
  =	
  1 − (1 − 𝑝)! 	
  
identifies	
  the	
  number	
  of	
  users	
  needed	
  to	
  identify	
  a	
  certain	
  percentage	
  of	
  
usability	
  issues	
  
where	
  	
  𝑝	
  is	
  the	
  average	
  proportion	
  for	
  a	
  test	
  and	
  𝑛	
  is	
  the	
  number	
  of	
  users	
  
1 − (1 − 𝑝)! 	
  
1 − (1 − 0.49)! 	
  
1 − (0.51)! 	
  
1 − 0.0089741	
  
~.991	
  or	
  99.1%	
  of	
  usability	
  issues	
  

Figure 3-7. Probability of Detection
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DESIGN CONSIDERATIONS
Interviews with older adults continued until no new insights were gained.
Participants’ interview responses were transcribed, coded, and analyzed for recurring
themes. One researcher analyzed data initially to create a coding guide. Afterward, two
researchers met several times to discuss the guide and update it based on their
independent views of the data. The researchers then used the guideline to code the
interview transcripts. NVivo 10 was used for final coding and analysis and a coding
comparison of all themes yielded an average percent agreement of 99.176% and an
average Kappa of .851746 indicating excellent agreement. Five design considerations
were identified that participants found useful to help with the tasks of selecting
appropriate over-the-counter medication.

Tunneling - Guided Persuasion
The prototype was designed to guide participants through the process of selecting
an OTC medication (See Figure 3-3). Varying information about the medication was
highlighted at each step of the process, participants provided input about conditions and
medications and at the end a decision of whether or not the medication was appropriate
was provided. The information highlighted in the prototype was based on the Federal
Drug Administration Drug Facts guidelines and was presented in chunks based on the
grouping presented in the guidelines. As mentioned earlier, the interface was designed
purposefully to provide tunneling or guided persuasion in order to motivate consumers to
use OTC medication information in the OTC decision-making task. When asked to
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discuss the wizard-like interface, all participants in the study (n=7) expressed a favorable
impression of the wizard concept. For example, Participant 1 commented on the
usefulness of the approach:
“I like the wizard approach, stepping people through and going down different
paths depending on the response” (P1)

In short, participants discussed that having the system guide them through the
process of selecting a medication was something they viewed as beneficial for the
prototype and useful for helping with an OTC decision-making task.

Personalization, Tailoring, and Decision Support
Although the prototype was tailored to the design needs of older adults, the
original prototype provided a limited degree of personalization. Participants were
presented with conditions and medications that might potentially conflict with the OTC
medication that they were considering and were asked to check any that apply. While
most participants liked this approach, it only acted as a data gathering step to provide data
to the prototype’s decision support algorithm. However, some participants suggested that
the system should have an option for providing a higher degree of customization at the
individual level. Participant 4 stated:
“My wife has a thing called Sweet’s syndrome. She can’t take any steroids. I
believe one of the things in here was some sort of steroid, as an inactive ingredient. One
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of the things … you need to have a person maybe list the conditions that they have at the
beginning so that they can weed out the medications that they definitely can’t take.” (P4)

Similarly, when asked if she felt the prototype provided enough information,
another participant stated:
“It didn’t say this medicine may affect people who have diabetes … It should be
listed if it’s going to interfere with people with diabetes I think it should be listed.” (P3)

The condition mentioned by Participant 4 was not included in the warnings
section of the medication box and therefore was not included in the prototype. However,
some participants discussed in the interview that they wanted more individualized
information. Participants discussed having the ability to input information about
medications or conditions before using the system. Others mentioned going beyond the
information on the label to include other information such as potential
condition/ingredient interactions that may not be specifically stated on the label, which
suggests another degree of reasoning of the data that was not provided by the prototype at
the time of this study.

Trust and System Recommendation
To spark discussion in the interview sessions, alternative screen mock-ups were
included that only provided participants with information about an OTC medication they
were considering. In comparison with the high-fidelity prototype in which the participant
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first interacted, the alternative mockup did not prompt the user to select any medications
or conditions they had or were taking; and did not provide a recommendation of whether
the medication was appropriate.
To the surprise of the researchers, all participants (n=7) indicated a system that
provided a recommendation would be more beneficial to them than a system that
provided information only. The researchers were torn on whether or not users would
trust or find a recommendation provided by a machine useful. This is a well-known
concern when designing persuasive technology (Fogg, 2002). However, when asked, all
participants (n=7) indicated they would be comfortable acting on a recommendation
made by the system and preferred the prototype that made a recommendation over the
prototype that only provided information. On the other hand, most participants also
discussed the need for a stronger disclaimer/language to ensure consumers would be
aware that the system did not replace the advice of a medical professional.
Participants also talked about the benefit of having the system provide alternative
medication options if the medication they selected was not appropriate. This feature was
provided as an alternative to receiving a message stating that the medication is not
appropriate. All participants (n=7) preferred to receive recommendation of other
medications that might be appropriate as opposed to a “not appropriate” message only.

Consumer-Friendly Health Language
The prototype provided consumer-friendly explanations of different medical
terms with the goal of helping participants better understand the overall risks or warnings
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being presented to them. This was an attempt to simplify the medication information and
motivate consumers to complete the task. Although most participants did not notice this
option when interacting with the prototype, all participants later indicated that the
consumer-friendly explanations of medication terms would be beneficial to helping them
better understand the information if they needed it. Participant 4 stated:
“I think people would know I’m taking something for anxiety or I’m taking
something for depression. They may not even remember the name of it. I don’t pay
attention. I take blood pressure medication and cholesterol medication. When I fill out a
form what medication I’m on, I can’t remember.” (P4)

Another participant discussed his frustration with medication information and
why he felt language support was useful:
“It’s intimidating because it’s so much information and what am I supposed to do
with it? Am I supposed to understand it? Am I supposed to recognize those chemicals?
It’s a bit intimidating.” (P6)

Although most participants indicated that they found the language support useful,
the interview data also reveals that more attention needs to be paid to how consumerfriendly language can best assist in the task at hand. For example, most participants did
not think that the inactive ingredients needed explanation although they too can be seen
as complex medical terms. On the other hand, some participants describe that they would
like to be alerted of potential interactions with ingredients. Most participants indicated
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that the explanations provided about medications in the warnings section were useful but
data reveal that the concept of providing consumer-friendly language should be further
studied to understand what information should be included, the language that should be
used, and how to increase the visibility of the feature.

Support for Sharing
Initially, the prototype presented to the participants did not include any options
for sharing information about an OTC medication selection or the results obtained from
the system. However, interview data revealed that options for sharing the information
provided by the system might not only be helpful for making an independent decision,
but also for initiating discussions with the pharmacist or doctor. The words doctor,
pharmacist, drugstore man, and druggist (pharmacist) were mentioned 34 times by
participants over all interview data. Six of the seven participants discussed that they may
talk with a doctor or pharmacist in addition to using the system, if they had follow-up
questions or were still unsure about a medication.

Participant 5 stated:

“I mean, you’re always going to need the pharmacist’s help, … but this would
help you… that would save … you can find a lot of stuff yourself” (P5).
The other five participants made similar comments in their interview. This
suggests that the system was viewed as designed, a supplement (not a replacement) to the
doctor or pharmacist. However, the data also reveals the importance of providing users
with information that can assist in their conversations with the doctor and/or pharmacist.
This feature was not considered as a primary concern in the preliminary design.
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However, interviews suggest that providing sharing options that support communication
between the consumer, doctor and/or pharmacist may also be beneficial to assisting in the
decision-making process. Keeping the consumer informed helps them to become more
knowledgeable and aware of their own medication management practices. This can help
to create an informed consumer that comes to the conversation more ready to participate.
Sharing also provides the doctor with information on how his or her patient’s medication
practices at home and helps to facilitate a conversation in which the consumer already has
some knowledge or stake.

DISCUSSION AND CONCLUSION
Including older adults in the early stages of design for this novel technology
helped to refine the initial prototype design and also helped to refine the initial model of
how technology can be used to support older adults in this task (See Figures 3-8 & 3-9).

Figure 3-8. Initial Model of OTC Decision-Making Technology Support Mechanisms
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Figure 3-9. Revised Model of OTC Decision-Making Technology Support Mechanisms

Initially, the prototype included four types of technology support mechanisms in
the design. The initial design included the concept of tunneling or guiding the user
through a set of defined steps. This helped to highlight information that was important
for older adults to consider when selecting an over-the-counter medication. The
prototype was designed for the older adult population using guidelines (e.g. font-size)
that are suited for the older population. In addition, the design included consumerfriendly health language provided through automatic generated explanations of health
terms and decision support of whether or not a medication was appropriate given the
users input. Obtaining feedback from older adults helped to refine this model by
identifying other ways technology could support the OTC decision-making process.
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In addition to the initial support mechanisms, data revealed that technology could
also be helpful by providing the user with system recommendations through information
filtering of user data to predict other medications that may be appropriate. Users
expressed that they would also be interested in having more control over the system’s
input and output. Some participants expressed the need for a more individualized level of
personalization by allowing input of information about chronic illnesses or medications
to help refine the decision support. Similarly, some participants also discussed going
beyond the information on the box to include other information about potential
interactions that might be beneficial to the decision-making process. This also included a
suggestion for including an additional level of reasoning for identifying potential adverse
reactions to the medications ingredients. Finally, because nearly all users stressed the
importance having the option to keep the pharmacist/nurse/or doctor in the over-thecounter medication process in some way, user-controlled information sharing was added
to the model to not only support consumers in the decision-making process, but also to
help facilitate discussions about potential OTC medications with persons of their
choosing.
Helping consumers understand health information is a challenging task (Nielsen-‐‑
Bohlm,  2004). OTC medications are of particular concern among older adults, however

some believe that technology can help address this challenge (Healthy People, 2010;
Martin, Jones and Gilbert, 2013; Neafsey, Strickler, Shellman and Chartier, 2002). The
goal of this study was to refine the design, understand, and explore technology features
that may be beneficial to assisting older adults in this task. Through expert review and
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brainstorming, researchers designed a concept for a novel prototype system to help older
adults with OTC medication selection. In addition, seven older adults users were
engaged in user sessions to identify usability issues in the initial prototype system and to
identify features and functionality that might be useful in system designed to assist with
over-the-counter medications. Nine usability issues were identified by 7 users in the
current design representing a probability of detection of .917. Therefore, 99.1% of
usability issues would be identified with the 7 users included in the study. In addition,
five design considerations were identified for technology to assist older adults in the task
of selecting appropriate OTC medications.

LIMITATIONS AND FUTURE WORK
The results of this study provide discussion of the process of designing an
interface that supports older adults in the OTC medication decision-making process.
Through user sessions with older adults, existing usability concerns were identified
(Tullis and Albert, 2008). In addition, qualitative data was collected to identify ways
technology can support older adults in the over-the-counter decision-making process.
Because no such technology currently exists for assisting older adults in these tasks, it
was important to gain feedback early in the design to understand what features and
functionalities provided by technology would be most supportive in this task. The study
included several rounds of expert review and interviews with seven participants (age
65+), which is more than the recommended number of participants for usability testing
(Lewis, 1994; Nielsen & Landauer, 1993). A rich, thick description (Creswell, 2013) of
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the study and its participants is provided and although user sessions were conducted until
no new data emerged from the accompanying interview with participants, the study may
be limited by number of people interviewed. Therefore, additional studies will be
performed on the revised prototype to determine if the findings of this study can be
generalized to a larger population.
The design considerations, feedback, and model identified in this study will be
used to inform the design of current and future technologies developed to help with OTC
decision-making tasks. The data from the expert review and study with older adults
revealed several opportunities for technology to support older adults in the OTC decisionmaking tasks. The new model will be used to guide design changes in the current
prototype interface and to guide the implementation and study of other technology
support mechanism (e.g. decision support algorithm, health text-simplification approach)
that will be included in the system implementation. Although many of the features
identified relate specifically to the task of selecting appropriate over-the-counter
medications, some considerations may be useful to the design of other consumer-decision
making applications for older adults.
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CHAPTER FOUR
DESIGNING AND EVALUATING A PROTOTYPE TRANSLATOR TO SUPPORT
OLDER ADULTS COMPREHENSION OF OVER-THE-COUNTER MEDICATION
INFORMATION
ABSTRACT
Understanding health information is a huge public health concern that affects
many in the population. Every year thousand are injured or die due to adverse
medication interactions. Over-the-counter medication (OTC) can be purchased at will by
consumers and contribute to a number of adverse medication interactions. Older adults
are at higher risk of adverse medication interactions due to factors related to aging.
Technology is thought to be advantageous for communicating health information to
various users. Further, technology that is customized to the needs of the target population
has been found to improve health outcomes.
This study evaluates the feasibility of a prototype translator designed through a
human-centered process that simplifies over-the-counter medication information for older
adults. This study is part of a larger Exploratory Sequential Mixed-Methods study that
aims to understand how technology can be used to improve the understanding of OTC
medication among the older adult population. The effectiveness of the prototype
translator for providing patient-centered information about OTC medication compared to
information that does not use the translator was evaluated. Older adults were asked to
participate in an experiment that examines the effect of the translator on the participant’s
beliefs about the difficulty of the information. The experiment followed a within study
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design. Perceived difficulty of the information, participants’ confidence in using the
information and their belief about how much control they have over using the
information to complete the tasks was measured. In addition, participants were asked to
answer comprehension questions to determine if the technique makes the process of
understanding the information less difficult. Results suggest that the prototype translator
may improve beliefs about self-efficacy, the participants preferred using the translator,
and the participants found the translator helpful for understanding the OTC medication
information.

INTRODUCTION
Helping consumers understand health information is a sizable public health
concern (Nielsen-Bohlm, 2004). In a non-clinical setting, consumers often rely on clear,
easy to understand health information to make important decisions regarding their health.
Tasks such as choosing appropriate over-the-counter medication (OTC) become
primarily the responsibility of the consumer. Quality measures exist to support consumer
safety and improve consumer knowledge but gaps in communication still exist putting
consumers at risk (DeWalt, 2010; Institutes of Medicine, 1999). This research focuses on
improving the communication of OTC medication information to the older adult
population.
Advances in technology provide new opportunities and mediums for
disseminating and communicating medication information to various user groups.
Coupling effective communication with health information technology is thought to
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improve the consumer experience irrespective of computer skills, and may lead to
improved health outcomes (Radvan, Wigger, & Hazell, 2004). To date, researchers have
explored ways of designing computer-based medication interventions that can assist
various populations with different aspects of their medication management regimen
including: scheduling, ordering, compliance or adherence, concordance and/or
medication education (in-hospital or at home) (Bickmore, Pfeifer and Jack, 2009;
Hoogendoorn, Klein, and Mosch, 2008; Qudah, Leijdekkers, and Gay, 2010; de Oliveira,
Cherubini, and Oliver, 2010; Silva, Mouttham, and El Saddik, 2009; Siek et al, 2011;
Wilcox, Feiner, Liu, Restaino, Collins, and Vawdrey, 2012; Neafsey, Strickler, Shellman
and Chartier, 2002; Harjumaa, Isomursu, Muuraiskangas, and Konttila, 2011). However
little to no research has focused on the specific task of OTC decision-making especially
among the older adult population. Like some of the other medication management tasks,
OTC decision-making requires the consumer or another vested party to take on a role that
a healthcare provider might administer in a clinical setting (e.g. administering
medication, ordering medication). However, this task is unique in that, the consumer or
other vested party must also take on the task of understanding the medication information
provided, the benefits and risk, how the medication may or may not fit into his or her
existing regimen, and/or how the medication may affect his or her existing health all with
little or no healthcare provider oversight (DeWalt, 2010; Institutes of Medicine, 1999).
The consumer in some way takes on a role that is similar to a healthcare provider but may
not have the training of a healthcare provider. For older adults, the task of choosing
appropriate OTC medication is made more complex due to factors related to the natural
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process of aging. Therefore, this study extends previous research by taking a first step at
exploring ways technology may be useful in the OTC decision-making process for older
adults. The study will evaluate the feasibility of a prototype translator that was designed
to address one of the barriers to communicating OTC medication information, complex
medical terminology, identified in a preliminary study with older adults.
This study was conducted in locations within the local community with adults 65
years and older. Community dwelling older adults were chosen because the prototype
translator used in this study is being evaluated for use in an intervention tailored to the
needs of older adults that select or purchase their own OTC medication. Older adults
participated in an experiment that examined 1) perceived difficulty, self-efficacy, and
controllability 2) comprehension and 3) actual difficulty. Well-developed measures for
evaluating information difficulty and OTC medication comprehension were used. In
addition, observational measures (event coding and task completion of comprehension
questions) were recorded and an informal questionnaire was administered at the end of
the interview to collect information preferences, helpfulness, and suggested
improvements. Therefore the specific aims of this study were to:
1. Evaluate the feasibility and effectiveness of a prototype translator designed to
reduce the difficulty of OTC medication information for community-dwelling
older adults.
2. Identify additional opportunities for the prototype translator to reduce the
difficulty of OTC medication for older adults.
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BACKGROUND AND RELATED WORK
Over-the-Counter Medication and Consumer Safety
Every year thousands die or are injured due to adverse drug events (ADEs) as a
result of taking medication (DeWalt, 2010; Institutes of Medicine, 1999). Overall,
medication interactions have been found to be the main cause of ADEs. Although
legislation exists that provides guidance for accurate and easy-to-read labeling for
medication, ADEs due to medication still occur (United States Food and Drug
Administration, 2009). Furthermore, older adults or individuals 65 years and older are
potentially at higher risk of ADEs due to several factors. Unlike prescription medication,
OTC medication can be purchased at will by a consumer and requires the consumer to
facilitate the process of determining if the medication is appropriate given their health
history (DeWalt, 2010; Institutes of Medicine, 1999). Older adults account for nearly
40% of all OTC medication use, use twice as many OTC medications compared to
prescription medications and on average, take between 6 and 9 medications concurrently
(Conn, 1992; Glaser and Rolita, 2009; Rolita and Freedman, 2008 ). Older adults are
also at higher risk for chronic illness, placing them at increased risk of drug-disease
interactions. Older adults also tend to have lower health literacy levels compared to other
age groups meaning that older adults may find it more challenging to “understand and act
upon health information” (Nielsen-Bohlm, 2004). Therefore, OTC consumer decisionmaking can become daunting and complex task for older adults (Martin, Jones, and
Gilbert, 2013; Neafsey, Strickler, Shellman and Chartier, 2002). This research therefore
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focused on evaluating the effectiveness and feasibility of translator designed for older
adults that aims to reduce the difficulty of OTC medication information.

Challenges to Communicating Medication Information
Currently, the primary information source for OTC medication information is the
OTC medication label or Drug Fact Label (United States Food and Drug Administration,
2009). The purpose of the label is to orchestrate a complex set of behaviors by the
consumer (Brass and Weintraub, 2003). Most consumers who decide to read the label
use only the label to make his or her decision and many do not read the label at all (Brass
and Weintraub, 2003; Covington, 2006). Several studies have identified barriers to
communicating OTC medication information through a print medium and have suggested
improvements for making medication information more useful and useable by different
populations (Brass and Weintraub, 2003; Klein and Issacson, 2003; Morrow, Weiner,
Young, Steinley, and Murray, 2003; Sansgiry, Bix, Clarke., and Pawaskar,2005).
However, print mediums still have limitations. Some researchers believe that technology
may be a potential medium for addressing some of the limitations of print-based text
(Healthy People 2020; Gibbons et al, 2009).
Consumer Health Informatics (CHI) is an area of public health that is concerned
with how to communicate health information to consumers through technological means
(Gibbons et al, 2009). CHI researchers attempt to “analyze” consumers’ need for
information; and study and implement methods for making information usable to
consumers (Eysenbach, 2000). A review of CHI literature shows that CHI applications,
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in particular those that include tailoring, personalization, and/or behavioral feedback
contribute to favorable health outcomes (Gibbons et al, 2009). Both tailoring and
personalization involve building customized interventions based on knowledge of an
individual’s or group’s characteristics (Gibbons et al, 2009). This research focuses on
evaluating a tailored intervention designed for older adults through a human-centered
design process. Data gathered from prior studies informed the design of the first version
of the translator that is used in this study. Additional opportunities for reducing the
difficulty of OTC medication for older adults will be identified in this study and
integrated into forthcoming versions of the translator.

Human-Centered Text Simplification
Simplifying text is a one way to reduce the complexity of text. Government
advocacy groups have emphasized the importance of the role of simplified text for
helping consumers better understand health information (Center for Plain Language,
2012; PlainLanguage.gov, 2012; U.S. Department of Health and Human Services, 2012).
The Plain Language Act of 2010 requires federal agencies to use “clear Government
communication that the public can understand and use” (U.S. Congressional Committee
of Oversight and Government Reform, 2010). PlainLanguage.gov was created to provide
guidelines to the public on how to comply with the law (PlainLanguage.gov, 2012).

Similarly, in Natural Language Processing, researchers have created techniques
for simplifying health information automatically using various translators. This
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approach, known as text simplification, takes a sentence in a document, runs it through
the technique, identifies “difficult terms”, and systematically replaces the terms with
synonyms and/or explanations until the sentence has been simplified (Siddharthan, 2004).
This process is repeated until all sentences in the document have been simplified (See
Figure 4-1). Difficult terms and the level of simplicity needed is often defined by the
designer and often evaluated through readability testing (Kandula, Curtis, and ZengTreitler, 2010; Boyce, Hrakema, and Conway; 2010; Elhadad, 2006). Few studies,
evaluate the technique directly with users. This study examines the effectiveness of a
prototype translator designed for simplifying OTC medication information directly with
older adults users.

Figure 4-1. Text Simplification Process (Siddharthan, 2004)
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STUDY DESIGN
This study examines the feasibility and effectiveness of a prototype translator
designed to assist older adults with over-the-counter medication information. The
translator was designed through a human-centered process in which information needs
were gathered and later included in a prototype to elicit additional feedback from
participants. The results of prior studies were used to inform the design of the translator
being examined in the proposed study.
Due to the limited resources available to support automated text simplification of
health information, few studies exist that focus on designing and evaluating such
techniques. This study is innovative because no study has examined how to design a
translator for simplifying over-the-counter medication information automatically. In
addition, most studies that focus on automatic text simplification of health information do
not evaluate the effectiveness of the technique directly with the targeted user group.
Instead, most studies use readability testing (e.g. Flesch Kincaid, SMOG) to evaluate the
effectiveness of the technique for simplifying health information (Kandula, Curtis, and
Zeng-Treitler, 2010; Boyce, Hrakema, and Conway; 2010; Elhadad, 2006). Although
readability tests provide a indirect measure of how simple the information is, the
proposed study aims to understand if the technique impacts users intention to use the
medication information in the decision making process and also older adults
comprehension of the medication information. This study, therefore, aims to advance
previous research in this area by examining the effectiveness of the technique directly
with users from the target population as opposed to indirect measures. The goal is to
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better understand the effect of the translator on intention of older adults to use the OTC
medication information in their decision-making process and also to gain feedback on
how to improve future iterations of the technique.

THEORY OF PLANNED BEHAVIOR (TPB)
TPB definition and background
The theory of planned behavior has been used widely in healthcare studies that
focus on human action (Ajzen, 1991, 2002, 2013). In TPB, it is believed that human
behavior is guided by three types of beliefs: behavioral, normative, and control (See
Figure 4-2). Behavioral beliefs are “beliefs about the likely outcomes of the behavior and
the evaluation of these outcomes” (Ajzen, 1991, 2002, 2013). Normative beliefs are
“beliefs about the normative expectations of others and motivation to comply with these
expectations” (Ajzen, 1991, 2002, 2013). Control beliefs are the “beliefs about the
presences of factors that may facilitate or impede performance of the behaviors and the
perceived power of these factors” (Ajzen, 1991, 2002, 2013). These beliefs help to form
a behavior intention. According to the theory, an individual’s intention to perform some
behavior is indirectly influenced by one or more of the three beliefs. In addition, if given
enough actual control over a behavior an individual is expected to carry out the behavior
(Ajzen, 1991, 2002, 2013). Interventions that aim to change behavior should therefore
address one or more of the three factors. In other words, interventions that persuade
humans to change behaviors should focus on changing individual normative, behavioral,
and/or control beliefs. However, when choosing which factor(s) to address, it is
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important to consider the potential degree of change that can be made in the area being
targeted. Therefore, formative research can be a very important step on choosing which
belief(s) to target in an intervention (Ajzen, 1991, 2002, 2013).

Figure 4-2. Theory of Planned Behavior (Ajzen, 1991, 2002, 2013)

Why TPB?
The TPB is one of many theories about human behaviors, but is thought to be one
that is more suited for studies involving communication and media (e.g. computer-based
interventions) (Finnegan and Viswanath, 2008). When humans communicate, they
produce and exchange information using symbols and signs and communication is
thought to be a central tenant of understanding human behavior (Finnegan and
Viswanath, 2008). For studies examining the impact of media exposure on individual
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behavior, several theories have been used. However, expectancy value theories such as
the TPB are more often used and found to offer explanation for media effects on behavior
at the individual level.
In this study, the effect of the prototype translator (the media) on the control
beliefs (perceived difficulty and perceived controllability) of older adults will be
examined (Finnegan and Viswanath, 2008). According to the TPB theory, control beliefs
are often measured by a perceived control component. Although there is some guidance
provided for measuring perceived control, no single measure exists (Kraft, 2005). For the
purposes of this study, two measures will be used: perceived difficulty (self-efficacy) and
perceived control (controllability). Perceived difficulty is defined as a “person’s belief as
to how easy or difficult performance of the behavior is likely to be” (Ajzen, 1991, 2002,
2013). Perceived control is defined as “the extent to which a person perceives the
behavior to be under their control” (Ajzen, 1991, 2002, 2013). These components
together were used to measure older adults control beliefs about the difficulty of the OTC
medication information presented to them with and without the translator.
In a previous study, the difficulty of medical terms on OTC medication labels,
were found to be a barrier to communicating OTC medication information to older adults
(Martin, Jones, and Gilbert, 2013). In other words, the older adults interviewed found it
difficult to understand some of the medical terms that appeared on the OTC medication
label. A translator was developed to improve the difficulty of the medical terms and
provide older adults with more control over the task of using the label information to
decide whether or not an OTC medication is appropriate. Therefore, the OTC medication
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information simplified by prototype translator is expected to support more favorable
control beliefs and thereby increase older adults intention to use the label information for
making decisions about an OTC medication.

APPROACH
Simplification Technique
This study is part of larger Exploratory-Sequential Mixed-Method study on the
use of technology to assist older adults in the OTC decision-making process (Creswell,
2013). Prior to this study, a preliminary study was conducted that focused on the design
of the OTC medication translator being evaluated in this study. Information retrieval
approaches were identified for providing synonyms and explanations of complex medical
terms appearing on OTC medication labels. The synonyms and explanations were first
identified using a manual search method. The manual search method was informed by
results of previous studies that suggested that older adults may have trouble
understanding certain terms on the OTC medication label (e.g. chronic illnesses,
medication names) (Martin, Jones & Gilbert, 2013).

Building the Controlled Vocabulary
One limitation of providing automatic text simplification for health information is
that there are limited data sources (e.g. corpora, dictionaries, controlled vocabularies) that
exclusively support automatic translation from medical terminology to consumer health
terminology (Zeng & Tse, 2005). Therefore, one of the first steps in designing an
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automatic simplification technique was to identify data sources that could support the
translation from medical terminology to consumer health terminology. Because, the
purpose of the translator is to provide decision support, it was important that any data
source that was used be validated. As mentioned before, many resources for automatic
text simplification that are available do not exclusively support translation of medical
information. Further, many do not provide support for the translation of medical terms.
One of the few resources that showed promise was an effort by Zeng and Tse (2005) to
create an open-source consumer health vocabulary. However, after examining the
feasibility for this experiment, many of the terms that were identified were not yet
included in the database. Therefore, although this effort shows a move toward supporting
automated simplification of health text; it was not yet sufficient for use in this
experiment.
Because, an existing data source could not be identified, the researchers instead
created a controlled vocabulary from a validated paper-based resource. The Plain
Language Thesaurus for Health Communications published by the National Center for
Health Marketing, The Department of Health and Human Services, and the Centers for
Disease Control is a validated resource that provides plain language equivalents to
medical terms, phrases, and references (National Center for Health Marketing,
Department of Health and Human Services, and the Centers for Disease Control, 2007).
However, to date, the thesaurus only exists in paper-based form. For the purpose of the
experiment, the researchers created a script that parsed the document to create a digital
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version of the thesaurus. This served as the basis for the controlled vocabulary used to
support the tool.
Fifty medications were chosen randomly from the Food and Drug Administration
(FDA) Drug Database and were used as a training set. The FDA Drug Database uses
Structured Product Label Format (a type of XML). Medication manufacturers use SPL to
create labels that comply with FDA requirements use this format.

Currently there is no

Application Programming Interface (API) for accessing medication label information.
Therefore, the raw data files for Human OTC Medications were downloaded and used as
the overall data set for creating the technique. At the time of download there were 22,698
Human OTC Medications in the dataset. This data set included all OTC medications
including pain medication, allergy medication, and cough syrup, but also lotions, hand
sanitizers, and medicated lip balm. Therefore, the researcher chose randomly from the
set, selecting only medication that could be administered through ingestion (e.g. liquids
and tablets) until the training set included 50 medications.
To supplement the terms included in the Plain Language Thesaurus, the terms
included in the 50 medications in the training set were analyzed manually for potential
inclusion as a difficult term. In doing so, the researcher focused on identifying medical
conditions, chronic illnesses, and medication names/types because these were identified
in a previous study as being difficult to understand.

Two hundred unique difficult terms

were identified in the first round of manual analysis of the 50 medications. Terms were
compared with the terms in the Plain Language Thesaurus to determine if it could
sufficiently provide mappings to consumer-based terms. From this round of analysis, it
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was determined that although the Plain Language Thesaurus provided support for many
of the condition names, however many of the medications that had been identified as
difficult terms were not currently present in the database. Therefore, Medline Plus
Health Topics was used to provide definitions for the terms not included in the database.
Mediline Plus is a validated course of consumer-based health information. It
provides and API and a search tool for retrieving information about health terms. Fortysix additional terms were added to the database using Medline Plus. Terms in this group
appeared 388 times over all 50 documents. Definitions for the 46 additional terms were
generated using Medline Plus based on a “is a” rule meaning that the text following
TERM “is a” was used as the consumer health explanation equivalent. In total, the
controlled vocabulary created for this experiment includes 2689 terms with
corresponding consumer-based definitions. The vocabulary served as a database for the
translator for simplifying terms identified as difficult medical terms.

The Prototype Translator
The prototype translator implemented for this study borrows from the idea of textsimplification (See Figure 1). In simplest form, the process of text-simplification, lexical
simplification, involves mapping and replacing more complex terms to simpler terms or
phrases. While this may seem trivial, one of the major hurdles of this approach is finding
a dictionary to provide these one-to-one mappings (Zeng & Tse, 2005). Syntactic
simplification is the process of automatically restructuring complex sentences into
simpler sentences. When considering the idea of replacing terms with phrases or
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restructuring sentences, the syntactic structure of the sentence must also be considered
since the goal of text simplification is to make the text simpler while preserving the
meaning of the sentence (Damay, Lojico, Lu, Tarantan, & Ong, 2006).
The translator used for this project borrows from lexical simplification by
providing mappings from complex terms to their consumer-based equivalents (terms or
phrases). Lexical simplification was chosen as a first step because one goal of this study
was to determine additional ways to deliver the health information to user. In addition,
lexical simplification has been one to approach that researchers employ for simplifying
health text (Leroy, Endicott, Kauchak, Mouradi, and Just, 2013; Leroy, Endicott,
Mouradi, Kauchak and Just, 2012; Kandula, Curtis, and Zeng-Treitler, 2010). The
translator that was created was therefore designed to provide a 1-1 mapping to terms and
phrases provided in the controlled vocabulary.
The translator retrieves text from a database of medications, parses the text to
identify difficult terms, and provides simplified terms or explanations to the user in the
form of an alternative consumer-based term or phrase (See Figure 4-3). Difficult terms
were defined as any term appearing in the controlled vocabulary. The controlled
vocabulary included single terms such as “diabetes” and compound terms such as “bowel
movement”. Because some terms appeared both as a single term and as part of a
compound term (e.g. “allergic” and “allergic reaction”) in the controlled vocabulary,
when parsing the original medication text, the parser used a sliding window approach to
identify compound medical terms. In addition, before comparing terms found in the
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medication text with terms in the controlled vocabulary, punctuation was removed to
increase the hit rate for matches.

Figure 4-3. Translator Design

The original text was parsed at run-time and was modified to include interactivity
that provides alternative consumer-based term or phrase. This approach was taken in lieu
of replacement for two reasons. First, because of the nature of the domain being studied,
it was important not to alter the text in any way that would change the meaning of the
text. Second, for lexical simplification where there is a 1-1 match of terms the challenge
of restructuring sentences is minimized. However, when replacing terms with phrases,
one must consider if the sentence makes sense or if it needs restructuring. In the past,
researchers have addressed this through a manual review of the text after the
simplification has been completed (Leroy, Endicott, Mouradi, Kauchak and Just, 2012;
Kandula, Curtis and Zeng-Treitler, 2010). However, one of the design goals for this
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translator is that it is flexible enough to be used in a system “in the wild” where manual
review of the text after simplification would be cumbersome and inconvenient.
Supplementing or augmenting the original text with simplified alternative is another
approach that removes the need for manual review and several researchers have found
this approach to be useful in lieu of full replacement of the text (Wilcox, Morris, Tan,
Gatewood, and Horvitz, 2011; Leroy, Endicott, Kauchak, Mouradi, and Just, 2013).

Testing the Translator
During training, the translator was designed to successfully replace the 246
difficult terms identified in the manual review of the medication documents. After
implementation, the translator was tested using another set of 50 medications chosen at
random from the FDA Human OTC Medication data set. Medications included in the
training set were excluded from the selection process. Similar to the training set,
medications were chosen at random from the entire set of Human OTC medications. If
the medication met the requirements for inclusion, it was added to the test set. This
process continued until there were 50 medications in the test set. The 50 medication
documents selected for the test set were scrubbed and included in a test database. This
database served as the data source for the translator.
Over the 50 documents included in the data set, 1357 1-1 matches were made,
1002 unique 1-1 matches were made, 536 near-match words were identified, and 368
unique near-match words were identified by the translator (See Table 4-1). On average,
27 1-1 matches were made per document, 20 unique 1-1 matches, 11 near-matches, and 7
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unique near-matches were made per document. A porter stem algorithm was included in
the translator to remove (“stem”) word endings and find near-match terms in the
controlled vocabulary.
1-1 Match Words

Unique 1-1 Match

Near-Match

Unique Near-

Identified

Words Identified

Words Identified

Match Words
Identified

Total Over All

1357

1002

536

368

7 - 53

7 - 40

2 - 25

2 - 14

27

20

11

7

Documents
Range Over
All
Documents
Average Per
Document

Table 4-1. Results of Translator Testing
Prototype Interface
An interface was designed to facilitate an experiment to better understand the
effect of the translator on perceived and actual difficulty of older adults’ understanding of
over-the-counter medication information. The interface was designed to display warning
information for four medications (See Figure 4-4). Medication information was queried
from the medication database and depending on whether the flag for the translator was
set, the interface presented information with or without the text translated. Therefore
each of the four medications had a translated and non-translated version.
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Figure 4-4. Screenshot of Interface Utilizing Translator

The four medications presented in the prototype included a medication for upset
stomach, a cold medicine, an allergy medication, and a pain reliever. These medications
were purposely chosen to provide variety and representation of the most widely used oral
over-the-counter medications. Apart from these categories, medication texts were chosen
to meet the criteria that each was approximately the same reading level. An 8th grade
reading level was chosen since it is the average reading level in the United States (See
Table 4-2). All documents had an approximate grade reading-level of 7th-8th grade and a
reading ease score of approximately 60, which suggests the documents, should be easy to
read for 13-15 year olds.
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Medication 1

Medication 2

Medication 3

Medication 4

Word Count

261

213

395

200

Unique Word

133

127

189

120

61.5

59.8

57.7

59.7

7.2

7.9

7.9

7.3

Count
Flesch-Kincaid
Reading Ease
Flesch-Kincaid
Grade Level

Table 4-2. Description of Medication Texts
Research Questions
To better understand the impact of the translator on perceived and actual
difficulty, and user satisfaction the following research questions were examined.

Research Question 1: Does the medication information simplified by the translator
generate more positive control beliefs among participants compared to medication
information not simplified by the translator?
a. Do older adults perceive the information to be less difficult when presented with
the translator compared to information not simplified by the technique?
b. Are older adults more confident when presented with information simplified by
the translator to identify risks and benefits of an OTC medication?
c. Do older adults believe they have more control of identifying risks and benefits of
OTC medication when presented with information simplified by the translator?
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Research Question 2: Is information simplified using the translator more effective at
communicating OTC medication risks and benefits compared to information that is not
simplified?
a. Is the number of participant errors reduced when using the translator?

Research Question 3: Does the translator increase task completion time?

Research Question 4: Were participants more satisfied using the simplified information
compared to the non-simplified information?
a. Did participants prefer using the simplified information compared to the
non-simplified information?
b. Did participants find the simplified information more helpful compared to
the non-simplified information?

METHODS
Participants and Study Location
This study is focused on improving OTC medication communication for those 65
years and older. In addition, the focus of this study is to improve communication for
older adults in the process of deciding appropriate OTC medication given their prior
health history. Participants of the study were therefore be required to be 65 years of age
or older and have experience purchasing or selecting their own OTC medication in the
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past year. The study was be conducted at two organizations within the local community
that cater to those older than 50.
Older adults were recruited through purposeful sampling from two organizations
within the local community. The lead researcher met with directors of the two
organizations to discuss the details of the study, what the study is about, and the
requirements for volunteering. The directors of the organization made first contact with
potential participants through email, flyers, or verbal announcement of the study.
Participants were asked to contact the lead researcher if they were interested in
volunteering for the study. Older adults were paid $15 for their participation.
Twenty-one older adults volunteered for the study. Approximately 62% of the
participants were female (N=13) and all but three participants were retired (N=18).
Eighteen participants were Caucasian and 3 were African-American. All participants
selected English as their primary language. Participants’ ages ranged from 64 – 90 (mean
~ 73 years, SD ~ 8 years). All participants were familiar with purchasing or taking overthe-counter medication.
Because the experiment was conducted using a computer, data was collected on
participant’s past use of computers and computational devices. All but 3 participants (N
= 18) used a laptop or desktop computer at least 3 or more times a week. Nine
participants used a smart phone or tablet device at least 5 or more times a week. Only
two participants did not use a computer, smart phone, or tablet device weekly. Nineteen
participants indicated that they used the Internet weekly. Eleven participants indicated
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that they used the Internet to search for information about prescription medication, while
only six used the Internet to search for information about over-the-counter medication.

Data collection methods
Institutional Review Board (IRB) approval was obtained before data was
collected. Each older adult participated in an experiment that examines the impact of the
translator on the perceived and actual difficulty of the OTC medication information.
Before the participant began, the participant was asked to complete a demographic and
computer use survey. This data was collected to 1) ensure the participant met the
participation requirements and 2) examine the impact of the participants experience with
using computers and using computers to search for medication information on the
proposed study. In addition, participants were asked to complete a verbal health literacy
test – REALM (Health Literacy Measurement Tools: Fact Sheet, 2009) to gauge how
well the participant may be able to “understand and act upon health information”
(National Center for Education Statistics, 2003). Participants in the study had on average
a REALM score of approximately 6 (SD ~ 2). However, eighteen of the participants had
a REALM score of 7, which is the highest score possible on the REALM test, meaning
that the group of older adults participating in this study should not have much trouble
understanding and acting upon health information.
After completing the REALM test, participants were presented with a
demonstration of how to use the translator. The information presented in the demo was
not related to medication but presented a short paragraph about a storybook character.
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The participant was allowed to get acquainted with how to use the translator and was told
that they may see similar options in the experiment. Each participant received 4 different
treatments (medications) during the experiment (See Table 4-3). Counterbalancing of
treatments between participants was used to reduce carryover effects due to practice or
fatigue. Medications were grouped based on the similarity of their grade level score so
that each participant received one simplified and one non-simplified version of each
medication at that approximate level. However, each text was different within each
group to reduce learning effects. The order in which participants received the treatments
was alternated for each participant. The dataset therefore included a total of 84
observations from the 21 participants.
Method of Delivery (W)
Translated

Not Translated

Grade Level of Text

7.2 & 7.3

N = 21

N = 21

(W)

7.9 & 7.9

N = 21

N = 21

Table 4-3. Experiment Design

Figure 4-5. Data Collection Process for Each Participant
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After being presented with the medication information, the participant was asked
to rate the difficulty, self-efficacy, and their perceived control of the medication
information on a 7-point likert scale (Kraft, 2005). The questions mapped directly to the
research questions and provided insight on the participants perceived control beliefs
regarding the medication information presented to them.

Each participant was also

asked several comprehension questions that were designed using the Food and Drug
Administration Comprehension Testing Guide (U.S. Department of Health and Human
Services Food and Drug Administration Center for Drug Evaluation and Research, 2010).
A Likert-Scale item along with the comprehension questions was used to measure the
actual difficulty of the OTC medication information presented to the participant. Finally,
for each medication, the participant was asked to identify any additional issues they
encountered with the OTC medication information. At the end of the experiment, the
participant was also asked to revisit the types of information (simplified vs. nonsimplified) used in the experiment and identify which type of information they preferred
using and which type of information they found more helpful and to provide any
additional suggestions.

Participant Observation
During the experiment, the researcher also recorded whether or not the participant
made use of supplemental materials provided to help them answer comprehension
questions. Time to complete comprehension questions was also recorded. Task
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completion time was recorded as the time interval beginning when the participant began
answering comprehension question until the participant completed the comprehension
questions. A structured coding form was used to record observational data for each task
in the experiment (Robson, 2011). This information was used to provide additional
insight on the difficulty of the medication information and shortcomings of the current
technique.

RESULTS
Self-Efficacy
Self-Efficacy is a person’s confidence that they can perform a behavior if they
wanted to do so (Ajzen, 2002). Self-Efficacy was measured using the 7-point LikertItem, “Finding risks and warnings using this information would be …”, anchored by very
difficult/very easy. For analysis, participants’ ratings were grouped in categories of
positive (ratings of 5, 6, or 7) and negative (1, 2, or 3). A rating of 4 was considered
neutral. Fifty-nine percent of observations were positive for the simplified information
compared to 47% for the non-simplified information. To understand the impact of the
translator on perceived self-efficacy, the proportion of observations in which ratings
changed from positive to negative (or vice versa) across treatment was analyzed. Fortytwo paired observations were included in the data set. The McNemar’s test for changes is
a nonparametric analysis that can be was used test for differences in proportions when
analyzing nominal, paired data. Thirty-one observations showed no change across
treatment groups. Nine observations moved from negative when participants were
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presented with non-simplified information to positive when presented with simplified
information. Two observations moved from negative when presented with the
experiment to positive when presented with the simplified information. The results of
McNemar’s provide sufficient evidence (df=1, N = 42) that participants’ beliefs about
self-efficacy differed significantly between the two treatments (P ~ .0348). Participants
were more likely to report positive beliefs about self-efficacy when presented with the
simplified text compared to the non-simplified text.

Table 4-4. Contingency Table for Self-Efficacy Ratings
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Figure 4-6. Result of McNemar’s Test

Perceived Control
Perceived Control is a person’s beliefs about how much control they have over
the targeted behavior (Ajzen, 2002). Perceived Control was measured using the 7-point
Likert-Item, “If I wanted to, I could find risks and warnings using this information”,
anchored by strongly disagree/strongly agree. For analysis, participants’ ratings were
grouped in categories of positive (ratings of 5, 6, or 7) and negative (1, 2, or 3). A rating
of 4 was considered neutral. Eighty-five observations had positive responses for both the
simplified and non-simplified versions of the text. To understand the impact of the tool
on perceived control, the proportion of observations in which ratings changed from
positive to negative (or vice versa) across treatment was analyzed. Forty-one paired
observations were included in the data set. The McNemar’s test for changes was used to
test for differences in the percentages. Twenty-nine observations showed no change
across treatments. Six observations showed a change from positive to negative and
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negative to positive. Results of McNemar’s test do not provide sufficient evidence (df=1,
N = 41) that participants’ beliefs about control differed significantly between the two
treatments (P ~ 1).

Table 4-5. Contingency Table for Perceived Control Ratings

Figure 4-7. Result of McNemar’s Test
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Perceived Difficulty vs. Actual Difficulty
Perceived and Actual Difficulty was measured using a 7-point Likert-Item,
anchored by strongly disagree/strongly agree. For analysis, participants’ ratings were
grouped into categories of positive (ratings of 5, 6, or 7) and negative (1, 2, or 3). A
rating of 4 was considered neutral. Fifty percent of responses about perceived difficulty
were positive when interacting with the simplified information compared to 38% of
responses for the non-simplified information. Further, when examining whether the
simplified information had any effect on actual difficulty, there was a significant
improvement in the proportion of participant whose ratings improved from negative
beliefs about difficulty to positive beliefs about difficulty when interacting with the
simplified information (W = -87.5, P ~ 0.0049). However, a similar trend was observed
for the non-simplified information.

Figure 4-8. Result of Wilcoxon Signed Rank Test
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Comprehension
Comprehension was measured using a 3-item questionnaire. The number of
participant errors included questions the participant answered incorrectly or questions for
which the participant did not know the answer. For both treatments, participants made 34
errors. Therefore, number of errors did not differ across treatments. To validate there
was no difference, the Wilcoxon Signed Rank Test was used to test for difference.
Results suggest there is not sufficient evidence to support that there was a significant
effect of treatment (W = -1.5, P ~ 0.5393) for reducing participant errors.

Figure 4-9. Results of Wilcoxon Rank Test

Task Completion Time
Task completion time was recorded on an observational coding sheet and was
defined as the interval between the participant completing the Pre-Survey questions and
completing the last question of the Comprehension questionnaire. Task completion time
was recorded for each of the four tasks the participant completed throughout the study.
The average task completion time for participants when using the simplified information
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was 3 mins/8 secs (185.03 secs). The average task completion time for participants when
using the non-simplified information was slightly higher at 3 mins/19 secs, an increase of
11 secs. The Wilcoxon Signed Rank Test was used to test for differences between
groups. Results suggest that there is not sufficient evidence (W = 5.5, P ~ 0.4721) to
support that there was a significant effect of treatment for increasing or decreasing task
completion time.

Figure 4-10. Result of Wilcoxon Rank Test

Observational Data
When asked to comment on difficulties or how the information could be
improved, participant responses varied widely. Many participants felt that the
information was well organized, easy to navigate and thorough. However, others
commented that they felt that formatting including spacing, font size, and organization
could be improved. In addition, several participants commented on the amount of
information, some felt that some of the information was unnecessary and others felt that
there was too much information crowded into the Warnings section.
Concerning the technique, most participants commented on terms such, as
“salicylates” that were not translated that they felt should be. This was consistent with the
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observational data collected for the number of times support materials were used.
Between the control and the experiment, participants used support materials 33 times
suggesting that some information was not readily clear and/or missing from the
information provided by the prototype. Three participants commented that they felt that
having certain words highlighted made the information easier to read, made it easier to
focus, and helped to organize the information. One participant felt that the simplified
terms were not helpful in their current form.

User Satisfaction
Two open-ended questions were used to measure user-satisfaction. Participants
were asked to discuss which version of the information (simplified vs. non-simplified)
they preferred using and which version of the information they found more helpful.
Participant’s responses to these questions were coded to fit in one of three categories 1)
Experiment (simplified version) 2) Control (non-simplified version) or 3) Neutral (no
strong preference). Nineteen participants responded to both questions and 2 participants
did not provide a response to either question. When asked to discuss which system they
preferred, 68% of participants expressed that they preferred using the translator, 26%
were in favor of the non-simplified information, and 6% were neutral. When asked to
elaborate on why they preferred the simplified text, nearly all participants commented
that they liked having the additional information available when and if they needed it.
One participant stated, “The pop-ups, because it provides additional information in
laymans terms”. Comments from the five participants who preferred the non-simplified
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information were more varied. One participant felt that not having the tool-tips forces a
person to focus more on the warnings. Another felt that the tool-tips were not necessary
and similar to the previous statement encouraged people to skim the information. A third
participant felt that the tool-tips made the information too complicated.
When asked which version of the information they thought were more helpful,
participants’ responses were the same as the responses for preference. Sixty-eight
percent of participants expressed that they preferred using the translator, 26% were in
favor of the non-simplified information, and 6% were neutral. When asked why they felt
the simplified text was more helpful, once again, nearly all responses alluded to having
simplified information available when needed. Of the 26% that found the non-simplified
text more helpful, similar to preference, responses were related to the complexity added
by the tool-tips or as one participant stated, “I found the highlights annoying”.
To determine if these observed frequencies for satisfaction deviated significantly
from the expected frequencies a One-Way Chi-Square Classification was conducted (See
Table 4-6).

Outcomes

Observed

Expected

(Fo – Fe)

(Fo – Fe)2

(Fo – Fe)2/ Fe

Experiment

13

6.33

6.67

44.49

7.03

Control

5

6.33

-1.33

1.77

.28

Nuetral

1

6.33

-5.33

28.41

4.49

19

19

X2 =11.80

df = 3 – 1 = 2
Table 4-6. Result of One-Way Chi Square Test
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Based on the Chi-Square reference table, a X2 of 5.99 or greater is needed for X2
to be significant at the .05 level. Therefore, a result of X2 of 11.80, suggests that there is
enough evidence to reject the hypothesis that the results of the study could have happened
by sampling error alone and the deviations between the observed and expected
frequencies are significant.

DISCUSSION & IMPLICATIONS
The goal of the study was to evaluate the feasibility and effectiveness of translator
designed through a human-centered process that simplifies OTC medication information
for older adults. In its current state, results suggest that the prototype translator evaluated
shows promise as a method for providing simplified OTC medication information to the
older adult population. Participants’ confidence in their ability to complete the task at
hand improved significantly from negative to positive when provided with OTC
medication information enhanced by the translator compared to information not
enhanced. In addition, a significant proportion of the participants preferred using the
information enhanced by the technique compared to information not enhanced.
Similarly, a significant proportion of the participants found using the information
enhanced by the technique more helpful than information not enhanced by the technique.
Although, results were not significant, participants provided more positive belief ratings
of perceived difficulty and the presence of the technique did not increase task completion
time.
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In addition, the study provides interesting insights on the feasibility of the
technique. With further improvement the technique may be a feasible option for
delivering simplified OTC medication information to users. Because of the number of
participants’ comments on formatting, coupling the technique with good information
presentation and design practices may improve the overall effectiveness of the translator
while further assisting participants with the task at hand. Participants’ comments also
reveal that some of the terms that were simplified did not need to be and others that were
not simplified should have been. From a technical standpoint, validated data sources to
support the tool are limited however research in this area is growing and several
promising resources exist. The Plain Language Thesaurus for Health Communications
provided a good starting point for building a controlled vocabulary for this study.
However, based on participants’ comments, more research is needed to better understand
how and when terms should be translated in the context of supporting OTC medication
understanding. Additionally, although the controlled vocabulary supported simplified
versions of several terms, there were terms that were not covered. Therefore, continued
research on creating data sources for consumer-based text simplification of health
information is needed. In particular, for this study, consumer-based explanations of
many of the medications and ingredients identified in this study were not covered in the
thesaurus and a good validated data source was not found elsewhere.
To summarize, the goal of this study was to examine the feasibility and
effectiveness of a technique for delivering simplified OTC medication to older adults.
Because there is limited research that examines that specific challenge of delivering
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simplified OTC health information to older adults, this study also provides a basis to
guide future studies. The technique evaluated in this study had a positive impact on
participants’ confidence in completing the task at hand. In addition, participants
preferred using the technique and found the technique more helpful than not using the
technique. Results suggest that with more research and further improvement, the
technique is a feasible option for providing simplified OTC medication information to
older adults. Additionally, the technique may increase user confidence and be a preferred
and helpful tool for navigating OTC medication information.

LIMITATIONS
Participants in the study were purposefully recruited and although participants
ranged in age, education level, and familiarity with OTC medications, most participants
had very high health-literacy levels. This may have impacted the study results as at this
level, participants are expected to easily understand and act upon health information.
Although, participants’ responses were varied, results may not be generalizable to a
group of participants with more varied health literacy levels. Therefore, in the future, a
different recruitment method will be employed to ensure that the sample includes
participants with more diverse health-literacy levels. In addition, in the future more
participants will be needed to detect significance differences at the .05 level based on the
differences observed in this preliminary study.
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CHAPTER FIVE
CONCLUSIONS & FUTURE WORK
The outcomes of this research have potential implications in several fields
including human-computer interaction (HCI), public health, consumer health informatics
(CHI), and information retrieval (IR). Specifically, the contributions of this research are
to:
1.

Better understand older adults current over-the-counter medication selection
practices and challenges and identify opportunities for technology to assist older
adults in the OTC medication selection process.

2.

Conceptualize and design a novel interface for assisting older adults with OTC
medication information and examine the usability of the novel interface for
assisting older adults with over-the-counter medication information in order to
identify aspects of the design and technology features that are useful and not
useful for assisting older adults with over-the-counter medication.

3.

Design a prototype translator that delivers simplified OTC medication
information to older adults and examine the effectiveness of the prototype
translator for affecting older adults control beliefs, comprehension, and
satisfaction of OTC medication information.

4.

Provide recommendations for improving future version of the translator and
similar techniques as well as suggestions for using such techniques in consumerbased technology that assist older adults with OTC medication.
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Obtaining user-feedback early and including users throughout the process are
cornerstones of HCI and UCD research. The design process and design
recommendations resulting from this work will help to further inform the design of
technology to address gaps in health-related communication, especially in older users. In
addition, this research highlights design considerations specific to older adults for
increasing the usability and effectiveness of technologies to communicate health
information. Similarly, this research also contributes to the field of consumer health
informatics. The design process and artifacts produced from this research will highlight
ways in which technology design can be used to better and more effectively inform older
adults of OTC medication risks and more generally, to address gaps in communicating
consumer health information. Finally, the results obtained from examining the prototype
translator designed and examined in this research provide insight on the feasibility and
usefulness of this and similar approaches in helping older adults understand OTC
medication information. This research suggests various ways in which these approaches
can be leveraged or improved to increase the usability CHI applications.
Although results from studies described in this dissertation provide several
contributions to various fields, because of the limited research in the specific area of
focus, much of the work in this dissertation was formative or exploratory. Therefore,
there are several opportunities to expand on the research presented in this dissertation.
Aspects of the prototype design and technology features that older adults find useful for
OTC medication selection were identified through a preliminary evaluation of the novel
prototype interface designed in this dissertation. In the future, further development and
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evaluation of the interface designed would be beneficial to further understand the impact
of the technology features on older adults short-term and long-term understanding of
OTC medication information. In addition, long-term evaluation of a functional prototype
may help researchers to further understand design requirements and the impact of the
technology for decreasing adverse drug events due to OTC medication among older
adults.
Evaluation of the prototype translator suggests that providing automatic
simplification of OTC medication information may affect older adults confidence in their
ability to navigate OTC medication information. In addition, older adults prefer using
information that provide support for simplified information and finds this information
more helpful. However, results also present several opportunities for future work. In
particular, many of the older adults who volunteered in this study had high health-literacy
levels. In the future, it would be beneficial to expand this study using a more purposed
and stratified sampling strategy, to understand the impact of the translator on older adults
with more varied health-literacy levels. In addition, although older adults found the
translator useful, results suggest that more research is needed to understand how and
when simplification support should be provided. For example, which terms need
simplification (hypertension or silicate), in what way should they be simplified (full
replacement or augmentation), and what are the tradeoffs (e.g. safety, reading ease).
Finally, qualitative results from the final study of this dissertation suggest that text
simplification alone may not be enough to assist older adults with the particular task of
OTC medication selection. For example, although participants had high health-literacy
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scores, the number of errors was high regardless of whether simplification support was
provided. Therefore, in the future, additional research that focuses on how to integrate
simplification techniques with other aspects of design or technology features and the
effectiveness of those strategies on older adults understanding of OTC would be
beneficial.
The major goal of this research was to better understand and abstract design
recommendations used to inform the design of a novel technological artifact and its
components that assists older adults in better understanding the risks and benefits of OTC
medications. Furthermore, this research aimed to determine the usefulness, usability,
and short-term effectiveness of that resultant artifact for improving understanding of
OTC medication risks for older adults. A three-phase human-centered approach
including formative research, user-centered design and evaluation was employed to
understand the design recommendations, produce artifacts, and answer the major research
questions. This dissertation describes the motivation for the research question(s) being
investigated and demonstrates two ways that technology is useful for communicating
OTC medication information to older adults. Future work in this area will be beneficial
to further understanding design requirements for helping older adults navigate the OTC
medication selection process. Additional research on the short-term and long-term
effectiveness of the artifacts produced in this dissertation will be beneficial to further
understanding the impact of these technologies on older adults understanding of OTC
medication information. Similarly, additional research is needed to better understand
how such technologies can be effectively integrated in the day-to-day lives of healthcare
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consumers to improve interactions with health information and improve healthcare
quality and safety for patients.
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Appendix A
STUDY I & II PROTOCOL & MATERIALS
Exploring the Design Requirements for Technology to Help Older Adults Identify
Potential Over-the-Counter Medication Benefits and Risks
Session I Protocol
Script
[Introductions]
I appreciate you taking the time to talk with us today. I would like to start by telling you a
little bit about our study and get your consent to participate.
[Present Participant with Informed Consent Form and Read Information]
This study focuses on creating technology to help older adult identify and understand
potential over-the-counter medication benefits and risks. Today, I would like to interview
you to learn more about you, your current medication management practices, how you
currently go about purchasing over-the-counter medications and the challenges you may
face, and also any technology you currently use or feel may be useful to support you in
this task. Before we begin, I would like to ask for your permission to audio record this
interview. This is for research purposes only and any identifying information will be
removed from the data.
[Wait for Response]
Do you have any other questions before we begin?
Background Information
1. What is your race/ethnicity?
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a. Black/African American
b. White/Caucasian
c. Asian/Pacific Islander
d. Indian
e. Native American
f. Hispanic
g. Other: Please Specify

2. What is your gender?
a. Male
b. Female
3. How old are you?
4. What is your primary language?
5. What is your highest level of education?
6. What is your occupation?
7. Which of the following most accurately represent your current living situation?
a. House/Apartment/Condominium
b. Independent Living Community
c. With Friends or Family
d. Other: Please Specify
Medication Management Practices
1. Do you currently take any medications (e.g. prescription)?
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2. If so, how many medications do you take on a daily/weekly basis?
3. Have you taken an over-the-counter medication (non-prescription) medication in
the last year?
4. On average, how many over-the-counter medications do you take per
week/month?
Current OTC Medication Purchasing and/or Selection Practices
Think about your experiences selecting and purchasing OTC medications. I will now ask
you questions related to purchasing or selecting OTC medications.
1. Do you purchase your own OTC medications?
a. If not, who purchases your OTC medications for you?
b. If so, do you always purchase your own OTC medication?
i. Who helps you purchase your OTC medications?
2. Say that you want to take a certain OTC medication for the first time. Describe
how you currently go about selecting and/or purchasing an over-the-counter
medication for the first time.
a. Do you ask someone for an opinion? If so, who do you consult.
b. Do you use the medication label or some other resource to make your
decision? If so, please describe.
c. Do you use technology in any way? If so, please describe.
3. Say that you want to take an OTC medication that you have taken before.
Describe how you go about selecting and/or purchasing an over-the-counter
medication that you have purchased before.
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a. Do you ask someone for an opinion? If so, who do you consult.
b. Do you use the medication label or some other resource to make your
decision? If so, please describe.
c. Do you use technology in any way? If so, please describe.
OTC Medication Information Challenges
1. Thinking back on your OTC medication purchases over the past year, describe
any challenges, if any, you have had with the information (e.g. OTC medication
label) used to make your decision.
2. I will like to now show you examples of OTC medication information and I
would like for us to discuss anything that you think may be challenging or helpful
for making a decision on whether this medication is appropriate for you to take.
•

Font-size?

•

Organization?

•

Language used? Where there words that you didn’t know.

•

Can you identify potential risks?

•

Did you understand the information in each section?

•

Is there something you feel that is missing?

•

Were there parts of the label that you found useful or liked about the label?

Technology Feasibility
As I mentioned earlier, we are looking at ways to design technology that could assist you
in understanding and identifying potential over-the-counter medication risks. We are in
the process of determining which type of technology may be useful in this task.
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1. Do you use any of the following on a weekly basis?
a. Smart Phone
b. Tablet or Pad
c. Kiosk
d. Desktop or Laptop Computer
e. Other. Please Specify
2. What type of tasks do you complete using these technologies?
3. What are you initial thoughts on potentially using one or more of these to support
you in making OTC medication-purchasing decisions? Do you have any
comments or concerns for using any of these?
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Verbal Recruitment Script
Clemson University
Exploring the Design Requirements for Technology to Help Older Adults Identify
Potential Over-the-Counter Medication Benefits and Risks.
Hello, I am Aqueasha M. Martin and I would like to look at ways that technology can be
designed and may be useful in helping older adults identify potential over-the-counter
drug benefits and risks. Each year, thousands of people die or are injured due to adverse
medication interactions. Over-the-counter drugs contribute to these numbers. The
potential risk of adverse over-the-counter drug interactions increase as we age due to the
natural process of aging and factors such as chronic illness that are prevalent among the
aging population. Because of this we would like to look at ways that technology can help
older adults identify and understand benefits and risks. Your participation in this study
will allow us to better understand the process in which older adults participate when
purchasing over-the-counter medications and the challenges you face, to determine the
appropriateness of various types of technology for completing the desired task, and/or to
better understand the what should be included in the design of technology that can assist
older adults in understanding the benefits and risks associated with over-the-counter
medications given your personal health history.
The study will require 45 minutes – 4 hours of your time depending on your desired level
of involvement. An introductory interview will be conducted and you will then be
invited back to participate in 1-3 follow-up interview that will help us understand the
design requirements for our technology. Each session will require approximately 45
minutes – 1 hour of your time. Participation in all parts of the study is voluntary and you
may withdraw participation at any time. Please know that I will do everything I can to
protect your privacy. Your identity or personal information will not be disclosed in any
publication that may result from the study. Notes that are taken during the interview will
be stored in a secure location.
Would you be interested in participating?
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PROTOCOL – SESSION II
Introduction (10 - 15 minutes)
• Introductions	
  
• Explain	
  Study	
  and	
  Get	
  Consent	
  
• Thanks	
  for	
  Participating	
  
Script
Investigator (I) Participant (P)
I: So, before we begin, I would like to explain a little more about what we will be doing
today. First, I will ask some background questions (if do not already have this
information). The goal of today’s session is to have you interact with 2 versions of paper
prototypes (screenshots) and get your feedback on those prototypes. I will provide you
with a scenario that you can follow and I will ask you questions after you complete each.
Basically, we are looking for you to help identify any concerns, things you like, or things
you don’t like so that we can make this a better project. Do you have any questions so
far?
[Ask questions on Background Information Sheet]
[Give participant first prototype have them walk through] (30-40 minutes)
Ask questions to elicit feedback on design choices (e.g. colors, font size, layout,
navigation), and to get a better understanding of the design requirements for technology
to assist older adults in the task of identifying OTC medication risks.
Potential Topics to Cover
Motivation for Use
Ease of Use/Look and Feel
Language Used in the System
Instructions on how to use the System
Alternative Medication Feature
Recommendation or Information System

Potential Prompts
Is this something they would use? What
would be the motivation?
(Alternative mock-ups)
Was it easy to use? Did you understand
everything? Did it provide enough info?
Likes, dislikes, concerns?
Issues with terms used?
Instructions helpful?
(Alternative mock-ups)
Would you use this feature? Would you
trust this feature? Amount of information
provided?
Which do you prefer? Why?
(Alternative mock-ups)

If this technology were available, would you use it? Why or why not?
Any other comments on how we can improve?
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Background  Information  –  Session  II  
1. What	
  is	
  your	
  race/ethnicity?	
  
e. Black/African	
  American	
  
f. White/Caucasian	
  
g. Asian/Pacific	
  Islander	
  
h. Indian	
  
i. Native	
  American	
  
j. Hispanic	
  
k. Other:	
  Please	
  Specify	
  	
  
2. What	
  is	
  your	
  gender?	
  
a. Male	
  
b. Female	
  
3. How	
  old	
  are	
  you?	
  	
  
4. What	
  is	
  your	
  primary	
  language?	
  
5. What	
  is	
  your	
  highest	
  level	
  of	
  education?	
  
a. Some	
  K	
  –	
  12	
  
b. High	
  school/K-‐12	
  
c. Some	
  College	
  
d. 4-‐Year	
  College	
  
e. Master’s	
  
f. Ph.D./Professional	
  Degree	
  
6. What	
  is	
  your	
  occupation?	
  
7. Which	
  of	
  the	
  following	
  most	
  accurately	
  represent	
  your	
  current	
  living	
  
situation?	
  
a. House/Apartment/Condominium	
  
b. Independent	
  Living	
  Community	
  
c. With	
  Friends	
  or	
  Family	
  
d. Other:	
  Please	
  Specify	
  
Medication Management Practices
5. Do	
  you	
  currently	
  take	
  any	
  medications	
  (e.g.	
  prescription)?	
  
6. If	
  so,	
  how	
  many	
  medications	
  do	
  you	
  take	
  on	
  a	
  daily	
  basis?	
  weekly	
  basis?	
  
7. Have	
  you	
  taken	
  an	
  over-‐the-‐counter	
  medication	
  (non-‐prescription)	
  
medication	
  in	
  the	
  last	
  year?	
  
8. On	
  average,	
  how	
  many	
  over-‐the-‐counter	
  medications	
  do	
  you	
  take	
  per	
  week?	
  
per	
  month?	
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Appendix B
STUDY III PROTOCOL & MATERIALS
Protocol
Hello, my name is Aqueasha Martin. I am a graduate student at Clemson. Thanks for
participating in our study. Before we begin, I would like to provide you with information
about the study and get your consent to participate.
[Provide participant with informed consent.]
I will give you time to look over the information and please let me know if you have any
questions.
[Give participant time to read document and ask questions]
Now that you have looked over the information, would you like to continue?
Before we get started with the experiment, I would like for you to complete a background
survey and a short exercise that sees how familiar you are with different health terms. Do
you have any questions?
[Background Survey & Health Literacy]
Thank you. Now, let me tell you how the rest of the experiment will go. On the
computer, you will be presented with a sample of some over-the-counter medication
information. You will then be asked a series of questions about the medication
information. You will be presented with 3 sets of questions for each of the sample overthe-counter medication information. You will receive one set at the beginning (presurvey), one set in the middle (comprehension survey), and one set at the end (postsurvey). Please use the sample over-the-counter medication information to answer the
questions. In total you will receive 4 versions of over-the-counter medication
information At the end of the experiment, I will ask you to complete a short questionnaire
about your experiences.
[Begin Practice]
Okay, now we will begin with experiment.
[Begin Experiment]
Thank you. Now I will ask you to complete a short survey about your experiences.
[Revisit Prototypes]
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[Final Survey]
Thanks for you participation.
[Provide Participant with Incentive – Signoff]
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Background Survey
Demographics
8. What	
  is	
  your	
  race/ethnicity?	
  
a. Black/African	
  American	
  
b. White/Caucasian	
  
c. Asian/Pacific	
  Islander	
  
d. Indian	
  
e. Native	
  American	
  
f. Hispanic	
  
g. Other:	
  Please	
  Specify	
  _________________________________	
  
	
  
9. What	
  is	
  your	
  gender?	
  
a. Male	
  
b. Female	
  
	
  
10. How	
  old	
  are	
  you?	
  	
  
	
  
	
  
11. What	
  is	
  your	
  primary	
  language?	
  

12. What	
  is	
  your	
  highest	
  level	
  of	
  education?	
  

13. What	
  is	
  your	
  occupation?	
  
14. Do	
  you	
  wear	
  glasses	
  or	
  contacts?	
  (If	
  No,	
  Skip	
  #9)	
  
Yes	
   	
  
	
  
No	
  
	
  
15. If	
  so,	
  are	
  you	
  wearing	
  your	
  glasses	
  or	
  contacts	
  today?	
  
Yes	
   	
  
	
  
No	
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Medication Background
1. Do	
  you	
  currently	
  take	
  any	
  over-‐the-‐counter	
  medications?	
  
Yes	
   	
  
	
  
No	
  
	
  
2. Do	
  you	
  purchase	
  or	
  select	
  your	
  over-‐the-‐counter	
  medications?	
  
Yes
No
3. Have	
  you	
  ever	
  taken	
  any	
  of	
  the	
  following	
  types	
  of	
  over-‐the-‐counter	
  
medications?	
  Select	
  all	
  that	
  apply.	
  
a. pain	
  relievers	
  such	
  as	
  Tylenol	
  or	
  Advil	
  
b. medications	
  for	
  upset	
  stomach	
  or	
  nausea	
  such	
  as	
  Pepto	
  Bismol	
  
c. sinus	
  medications	
  such	
  as	
  Benadryl	
  or	
  Allegra	
  
d. cold	
  medication	
  such	
  as	
  Nyquil	
  or	
  Robotussin	
  
Computer Use
1. Do	
  you	
  use	
  a	
  computer	
  often?	
  	
  	
  
Yes
No
2. How	
  often	
  do	
  you	
  use	
  the	
  computer	
  each	
  week?	
  
a. 1	
  -‐	
  2	
  days	
  per	
  week	
  
b. 3	
  -‐	
  4	
  days	
  per	
  week	
  
c. 5	
  or	
  more	
  days	
  per	
  week	
  
	
  
3. What	
  type	
  of	
  tasks	
  do	
  you	
  use	
  your	
  computer	
  for?	
  
a. Creating	
  documents	
  
b. Internet	
  
c. Games	
  
d. Finance	
  
e. Other:	
  __________________________________	
  
	
  
4. Do	
  you	
  use	
  a	
  smart	
  phone	
  or	
  tablet	
  device	
  often?	
  	
  	
  
Yes	
   	
  
	
  
No	
  
	
  
5. What	
  type	
  of	
  smart	
  phone	
  or	
  tablet	
  device	
  is	
  it	
  (iPhone,	
  iPad,	
  Andriod)?	
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6. How	
  often	
  do	
  you	
  use	
  the	
  smart	
  phone	
  or	
  tablet	
  each	
  week?	
  
a. 1	
  -‐	
  2	
  days	
  per	
  week	
  
b. 3	
  -‐	
  4	
  days	
  per	
  week	
  
c. 5	
  or	
  more	
  days	
  per	
  week	
  
	
  
7. What	
  type	
  of	
  tasks	
  do	
  you	
  use	
  your	
  smart	
  phone	
  or	
  tablet	
  for?	
  
a. Creating	
  documents	
  
b. Internet	
  
c. Games	
  
d. Finance	
  
e. Other:	
  _____________________________________	
  
	
  
8. If	
  you	
  use	
  the	
  Internet,	
  how	
  often	
  do	
  you	
  use	
  the	
  Internet?	
  
a. 1	
  -‐	
  2	
  days	
  per	
  week	
  
b. 3	
  -‐	
  4	
  days	
  per	
  week	
  
c. 5	
  or	
  more	
  days	
  per	
  week	
  
	
  
9. How	
  do	
  you	
  normally	
  connect	
  to	
  the	
  Internet	
  (computer,	
  phone)?	
  
	
  
	
  
10. Do	
  you	
  use	
  the	
  Internet	
  to	
  search	
  for	
  information	
  about	
  prescription	
  
medication?	
  
Yes
No
11. Do	
  you	
  use	
  the	
  Internet	
  to	
  search	
  for	
  information	
  about	
  over-‐the-‐counter	
  
medication?	
  
Yes
No
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Pre-Survey
Take a quick look of the medication information. Based on your first thoughts, please
answer the following questions.
(Please Circle One)
1) This	
  information	
  is	
  	
  
1. Very	
  Difficult	
  	
  
2. Quite	
  Difficult	
  	
  
3. Slightly	
  Difficult	
  
4. Neither	
  Difficult	
  or	
  Easy	
  
5. Slightly	
  Easy	
  
6. Quite	
  Easy	
  	
  
7. Very	
  Easy	
  
(Please Circle One)
2) Finding	
  risks	
  and	
  warnings	
  using	
  this	
  information	
  would	
  be	
  	
  
1. Very	
  Difficult	
  
2. Quite	
  Difficult	
  
3. Slightly	
  Difficult	
  
4. Neither	
  Difficult	
  or	
  Easy	
  
5. Slightly	
  Easy	
  
6. Quite	
  Easy	
  
7. Very	
  Easy	
  
(Please Circle One)
3) If	
  I	
  wanted	
  to,	
  I	
  could	
  find	
  risks	
  and	
  warnings	
  using	
  this	
  information.	
  
1. Strongly	
  Disagree	
  
2. Disagree	
  
3. Mildly	
  Disagree	
  	
  
4. Neither	
  Disagree	
  or	
  Agree	
  	
  
5. Mildly	
  Agree	
  	
  
6. Agree	
  	
  
7. Strongly	
  Agree	
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Post Survey
1)	
  Overall,	
  how	
  difficult	
  was	
  it	
  for	
  you	
  to	
  complete	
  the	
  questions	
  (Circle	
  One)?	
  
8. Very	
  Difficult	
  
9. Quite	
  Difficult	
  
10. Slightly	
  Difficult	
  
11. Neither	
  Difficult	
  or	
  Easy	
  
12. Slightly	
  Easy	
  
13. Quite	
  Easy	
  
14. Very	
  Easy	
  
	
  
	
  	
  	
  	
  	
  	
  2)	
  Why	
  did	
  you	
  choose	
  the	
  rating	
  that	
  you	
  did?	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
3)	
  Thinking	
  about	
  the	
  information,	
  was	
  there	
  any	
  part	
  of	
  the	
  information	
  that	
  
was	
  challenging?	
  	
  If	
  so,	
  please	
  share.	
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Final Survey
1) Thinking	
  about	
  the	
  two	
  ways	
  the	
  information	
  was	
  presented,	
  which	
  do	
  you	
  
prefer?	
  	
  Why?	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
2) Thinking	
  about	
  the	
  two	
  ways	
  the	
  information	
  was	
  presented,	
  which	
  do	
  you	
  
think	
  would	
  be	
  more	
  helpful?	
  	
  Why?	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
3) Do	
  you	
  have	
  any	
  suggestions	
  on	
  how	
  we	
  can	
  improve	
  how	
  the	
  information	
  is	
  
presented?	
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Oberservational Coding Sheet
Participant # _________________

Medication #

Control?

# Times used support
materials

Medication #1

Medication #2

Medication #3

Medication #4
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Task completion time

Rapid Estimate of Adult Literacy in Medicine – Short Form (REALM-SF)
Available on Internet: http://www.ahrq.gov/professionals/quality-patient-safety/qualityresources/tools/literacy/index.html
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